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ABSTRACT 
MICHELE ANN GAUGER:  Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints, and 
Cancer 
 (Under the direction of Aziz Sancar) 
 
 The mammalian circadian clock is a global regulatory system that controls many 
aspects of physiology, including behavior, metabolism, cell cycle progression, and overall 
fitness.  CRYPTOCHROMES (CRYs) are core elements of the mammalian circadian clock, 
and loss of CRY expression leads to arrythmicity.  Although much work has been done 
analyzing the mammalian clock, the molecular mechanisms underlying the clock and 
resulting from its disruption are still largely unknown.  There is growing evidence that 
circadian rhythm disruption in both humans and rodents leads to predisposition to cancer and 
poor prognosis; however, it has not been determined if cancer predisposition is a hallmark of 
all types of clock disruption.  Here I present evidence that arrhythmic Cry1-/-Cry2-/- mice 
possess an intact DNA damage checkpoint and repair system and are not predisposed to 
ionizing radiation-induced cancers relative to wild-type mice.  In addition, experiments were 
conducted to determine the direct effect, if any, that CRY1 exerts on CLOCK-BMAL1 
heterodimer DNA-binding.  I find that CRY1 neither inhibits nor modifies the DNA binding 
of a heterodimer consisting of BMAL1 and a 342-amino acid fragment of CLOCK 
(CLOCK342) in vitro.  However, this does not rule out the possibility that CRY1            
could have an effect on a heterodimer of BMAL1 and full-length CLOCK in vitro.  
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CHAPTER 1 
 
CRYPTOCHROME AND THE MAMMALIAN CIRCADIAN 
CLOCK 
 
 
Introduction 
The solar cycle is perhaps the most pervasive environmental stimulus for organisms 
on Earth.  Adaptation to this stimulus and ability to perceive changes in light conditions 
confers a selective advantage. The earliest application of this adaptation is thought to have 
evolved for the purpose of protecting replicating DNA from ultraviolet light during the 
daytime hours.  Since then, organisms ranging from cyanobacteria to humans have evolved 
mechanisms to synchronize physiological processes to the 24-hour solar day, allowing 
organisms to predict and prepare for constantly changing environmental conditions.  These 
mechanisms comprise an organism’s circadian (circa-24 hours) clock and regulate such 
processes as behavior, metabolism, cell division, sleep-wake cycles, body temperature, heart 
rate, and hormone production; indeed, most physiological functions undergo circadian 
oscillation (Rutter et al., 2002).   
The circadian clock exerts its control over physiological processes through finely 
tuned control of gene expression; it is estimated that up to 10% of cellular genes in mammals 
undergo circadian oscillation in expression (Panda et al., 2002).  Although the endogenous 
circadian clock maintains synchronization under constant environmental conditions, 
disturbance in clock synchronization by the solar cycle can result in physiological disorders 
in humans.   Under conditions of jet lag, a rapid change of local time causes the internal 
clock to not fully synchronize with the local time; this can result in fatigue, irritability, and 
has been shown to affect fitness and tumor growth in mouse models (Filipski et al., 2005; 
Filipski et al., 2006).  Rotating shift work is another example of environmental clock 
disruption that can lead to fatigue, insomnia, and has been associated with a higher risk of 
breast cancer in women (Hansen, 2000).  Molecular disruption of circadian rhythms in 
humans has been associated with seasonal affective disorder (SAD), familial advanced phase 
sleep syndrome, delayed sleep phase syndrome, cancer, and generally decreased fitness 
(Sancar, 2000; Stevens, 2005).  Although we have thus far gleaned much information on the 
mammalian clock, evidence towards the biochemical mechanisms underlying the clock are 
generally lacking.   
 
The Mammalian Circadian Clock 
Most eukaryotic organisms possess an intrinsic circadian rhythm with a periodicity of 
approximately, but not exactly, 24 hours (24.2 hours in humans (Czeisler et al., 1999), 23.5 
hours in mice).  These rhythms exist in the absence of external stimuli (i.e. in constant 
darkness) and are self-sustained in every eukaryotic cell, including cells cultured ex vivo 
(Nagoshi et al., 2004).   
Endogenous circadian rhythms in mammalian peripheral tissues are entrained to the 
exact 24-hour solar day through signals from a central circadian pacemaker organ.  In 
mammals, the central circadian pacemaker is located in the suprachiasmatic nucleus (SCN) 
in the hypothalamus (Hastings and Maywood, 2000).  The SCN consists of a cluster of 
neurons that exhibits robust light-induced changes in gene expression, with light signals 
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being received through visual photoreceptors and photoreceptive retinal ganglion cells.  The 
response of the SCN to light-induced changes is rapid, with complete entrainment to a shift 
in daily light-dark cycle occurring within one day of the change (Yamazaki et al, 2000).  
Photoentrainment of the SCN does not require vision (rod and cone photoreceptors in the 
outer retina); as such, blindness in humans and mice does not destroy the ability to 
synchronize the circadian clock (Sancar, 2000).  Rather, the non-visual photoreceptors in the 
inner retina are sufficient for complete photoentrainment.  The SCN is critical for 
maintenance of circadian rhythmicity (Ralph et al., 1990; Sakamoto et al., 1998; Rusak and 
Zucker, 1979).  Lesions of the SCN cause complete ablation of the circadian clock in rats 
(Klein et al., 1991).   The circadian rhythm machinery in the SCN is similar to that in all 
mammalian cells with the exception of photoreceptive capability.  This allows the SCN, 
through an uncharacterized signaling pathway, to reset an organism’s circadian rhythm phase 
according to the solar cycle and other environmental stimuli, called zeitgeibers (literally, 
“time-givers”).  Information from the SCN is passed onto the pineal gland, causing 
oscillations in secretion of the hormone melatonin.  Consequently, these signals are passed 
onto peripheral tissue clocks to synchronize and regulate transcriptional activity throughout 
the day.   
To date, there is a great deal of genetic evidence for the mechanisms underlying the 
mammalian circadian clock; however, biochemical characterization of the clock is lacking.  
Genetic studies have led to the formulation of the current model for the mammalian circadian 
clock, in which the clock is engendered mainly by the interplay of positive and negative 
transcriptional feedback loops (Figure 1.1; Gauger and Sancar, 2005).  Similar mechanisms 
have been indicated for all organisms whose circadian rhythms have been extensively studied 
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(Rutter et al., 2002).  At the center of these loops are the core clock proteins, whose gene 
products are necessary to maintain circadian rhythmicity in individual cells (Takahashi, 
2004).  The core clock proteins participating in this loop will be described in detail in Section 
1.3.  Four core clock proteins, BMAL1, CLOCK, PERIOD (PER), and CRYPTOCHROME 
(CRY), are particularly important in this model.  A heterodimer of BMAL1 and CLOCK 
participate in the positive segment of the transcriptional feedback loop, in which the 
BMAL1-CLOCK complex activates transcription of genes whose promoters contain E-box 
elements (CACGTG).  These genes include clock-controlled genes (CCGs) whose products 
are not directly involved in the circadian clock machinery, and also the core clock genes 
period and cryptochrome.  PER and CRY proteins, after transcription and translation, form 
the negative segment of the transcriptional feedback loop by inhibiting the BMAL1-CLOCK 
heterodimer through an unknown mechanism.  In this way, PER and CRY negatively 
regulate their own transcription.  In a second, minor feedback loop, the circadian proteins 
REV-ERBα and RORα regulate transcription of Bmal1 by repression and activation, 
respectively (Sancar, 2000; Wijnen and Young, 2006).  Rev-Erbα and Rorα are both targets 
of CLOCK-BMAL1-mediated transcription, thereby regulating their own expression.  In 
addition to the positive and negative transcriptional feedback loops themselves, other 
elements are believed to contribute to the 24-hour periodicity of oscillation of gene 
expression in the circadian clock.  These elements likely include regulation of protein 
accumulation in the cytoplasm/nucleus and/or posttranslational modifications; however, 
these regulatory elements have not been clearly elucidated yet. 
The canonical transcription-translation feedback loop (TTFL) model of the 
mammalian circadian clock has been challenged of late.  For some time it has been known 
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that in addition to contributions from the TTFL model, post-translational modification of the 
clock proteins occurs and is likely a component of their regulation (Lee et al., 2001).  In the 
clock system of the cyanobacterium Synechococcus, in which a similar TTFL had been 
implicated for many years, it has been recently shown that circadian rhythmicity can be 
reconstituted using purified proteins in a closed in vitro system (Nakajima et al., 2005; 
Kageyama et al., 2006).  This data indicates that, in at least one system, a circadian rhythm 
can persist in the absence of transcription or translation and is prompting serious re-
evaluation of the orthodox mammalian circadian clock model (reviewed in Lakin-Thomas,  
2006).   
 
The Core Circadian Clock Proteins 
 In the mammalian circadian clock, the four main core clock components are the 
Clock, Bmal1, Period (Per; Per1, Per2, and Per3), and Cryptochrome (Cry; Cry1 and Cry2) 
genes and their gene products, CLOCK, BMAL1, PER (PER; PER1, PER2, and PER3), and 
CRY (CRY; CRY1 and CRY2), respectively.  These four proteins comprise the positive and 
negative arms of the transcriptional feedback loops that engender the mammalian clock.  
Mutations in the core clock components result in the most dramatic clock phenotypes.  I will 
provide a detailed description of these components here. 
CLOCK 
 Clock was the first mammalian clock gene to be identified (King et al., 1997; Antoch 
et al., 1997).  Homologues of mammalian CLOCK have been found in Drosophila 
(dCLOCK) (Allada et al., 1998) and zebrafish (zCLOCK) (Ishikawa et al., 2002) and a 
complex orthologous to CLOCK-BMAL1 is formed in Neurospora (the White-Collar 
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Complex) (Wijnen and Young, 2006).  The mammalian Clock gene encodes a basic helix-
loop-helix (b-HLH) PAS protein that acts as a transcription factor when in complex with 
another core clock protein, BMAL1 (King et al., 1997; Antoch et al., 1997).  The CLOCK-
BMAL1 heterodimer binds to E-box elements in gene promoters, most notably the promoters 
of the Period (Per) and Cryptochrome (Cry) core circadian genes, along with circadian gene 
Rev-Erbα and many clock-controlled genes that do not participate in the clock itself.  
CLOCK has been shown to interact physically with not only BMAL1 but also the CRY and 
PER proteins (Lee et al., 2001).  Clock is somewhat unique among the four main clock 
component genes in that its expression does not oscillate and is not under circadian control; 
CLOCK protein levels likewise are constant throughout the circadian cycle (Lee et al., 2001).  
Mice homozygous for a mutation of Clock exhibit an abnormally long circadian period, 
becoming arrhythmic in constant darkness (Vitaterna et al., 1994).  CLOCK protein resulting 
from this mutation lacks residues encoded for in exon 19 of the Clock gene.  In heterozygous 
mutant animals, the mutant protein can compete with wild-type CLOCK protein (King et al., 
1997); in homozygous mutant animals, the mutant protein results in functionally defective 
CLOCK:BMAL1 heterodimers (Gekakis et al., 1998; Jin et al., 1999).  Interestingly, it was 
recently reported that CLOCK is not an absolutely essential circadian clock component 
(DeBruyne et al., 2006).  CLOCK-null mice demonstrate altered responses to light and 
alterations in circadian clock gene expression; however, they still display robust circadian 
rhythms as measured by locomotor activity.  The discrepancy between results obtained with 
CLOCK-mutant mice and CLOCK-null mice is hypothesized to be due to the dominant-
negative effect of CLOCK-mutant protein.  A CLOCK-redundant protein has been proposed 
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to heterodimerize with BMAL1 in the absence of CLOCK to maintain general circadian 
clock function; NPAS2 is a likely candidate for this.   
 In addition to DNA-binding and transcriptional activating activities, CLOCK has also 
been recently shown to have histone acetyltransferase (HAT) activity.  The carboxy-terminus 
of CLOCK shows significant structural similarity to the carboxy-terminus of the HAT 
protein ACTR (Chen et al., 1997) and CLOCK exhibits HAT activity in experiments using 
purified histones as substrates (Doi et al., 2006).  CLOCK’s HAT activity appears to be 
essential for its function in circadian regulation, as ectopic expression of a HAT-deficient 
CLOCK mutant protein in a homozygous Clock mutant background does not restore 
circadian transactivation of the Per and Dbp genes (Doi et al., 2006).  However, it is 
unknown what the effect of ectopic expression of HAT-deficient CLOCK in a true CLOCK-
null background will be.  The HAT activity of CLOCK indicates that regulation of histone 
acetylation may be involved in circadian gene expression and specifically CLOCK:BMAL1 
function.  This hypothesis supports reports that CLOCK interacts with histone acetylases 
(Etchegaray et al., 2003) and that histone modification displays circadian variation 
(Ripperger and Schibler, 2006).   
BMAL1 
 BMAL1 (sometimes referred to as MOP3) was originally found as a protein with high 
expression in mammalian brain and muscle (Ikeda and Nomura, 1997; Hogenesch et al., 
1997).  BMAL1 has homologues in Drosophila (CYCLE) (Rutila et al., 1998) and zebrafish 
(zBMAL1) (Ishikawa et al., 2002) and a complex orthologous to CLOCK-BMAL1 is formed 
in Neurospora (the White-Collar Complex) (Wijnen and Young, 2006).  Like CLOCK, 
mammalian BMAL1 is a bHLH-PAS transcription factor.  BMAL1 heterodimerizes with 
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CLOCK to activate transcription off of E-box-containing promoters, notably those promoters 
of the Per and Cry genes in addition to other CCGs.  While CLOCK-BMAL1 does not 
control transcription of Bmal1, this gene is still under circadian clock control as the orphan 
nuclear receptor RORα activates its transcription (Sato et al., 2004) and REV-ERBα, another 
clock protein, negatively regulates its transcription (Reppert and Weaver, 2002).  PER2 has 
also been shown to stimulate transcription of Bmal1, through an ill-defined mechanism 
(Hogenesch et al., 2003; Shearman et al., 2000). BMAL1 protein levels oscillate with 
circadian periodicity (Fu et al., 2002).  Loss of expression of mBmal1 causes complete loss of 
circadian clock function and therefore   Bmal1-/- mice are arrhythmic at both the behavioral 
and molecular levels (Bunger et al., 2000).  Additionally, a variety of other physiological 
phenotypes have been seen in Bmal1-/- mice, including decreased activity levels and body 
weight, joint disease, and shortened life span (Bunger et al., 2000; Rudic et al., 2004; Bunger 
et al., 2005; Laposky et al., 2005; Shimba et al., 2005; Kondratov et al., 2006; Sun et al., 
2006).  This suggests that BMAL1 may play tissue-specific roles in addition to its circadian 
clock function; this theory has been supported by a recent report (McDearmon et al., 2006).   
 BMAL1 undergoes post-translational modifications that are thought to contribute to 
its regulation.  Phosphorylation of BMAL1, and of CLOCK, correlates with CLOCK-
BMAL1’s transcriptional activity (Lee et al., 2001).  Also, BMAL1 has been shown to be 
sumoylated in a CLOCK-dependent manner (Cardone et al., 2005).  The C-terminus of 
BMAL1 (specifically the section containing the last 43 amino acids) has been recently 
demonstrated to be required for its transcriptional activation activity as well as for its 
interaction with CRY1; this process is also dependent on the presence of CLOCK (Kiyohara 
et al., 2006).  This portion of BMAL1 is not necessary, however, for association with PER2.  
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BMAL1 has been found to interact physically with CLOCK, CRY, and PER proteins in what 
may be a large clock-protein complex (Lee et al., 2001).   
 BMAL1 has been shown to be important in the regulation of the CLOCK-BMAL1 
heterodimer.  Nuclear accumulation of CLOCK protein and its subsequent degradation is 
largely dependent on BMAL1, through a poorly-understood mechanism (Kondratov et al., 
2003).  In support of this, Kwon and colleagues have recently reported that 
nucleocytoplasmic shuttling of BMAL1 is necessary for the transactivation and degradation 
of CLOCK-BMAL1 (Kwon et al., 2006).   
PERIOD  
 The Drosophila period gene was first cloned in 1984, spawning a search for its 
mammalian homologue.  Eventually three mammalian homologues were identified (Per1, 
Per2, Per3) and cloned (Albrecht et al., 1997; Zylka et al., 1997; Shigeyoshi et al., 1997; Sun 
et al., 1997; Tei et al., 1997).  All three mammalian Per genes display homology to 
Drosophila period and oscillation in both the SCN and the retina (Whitmore et al., 1998).  
PERs are PAS-domain proteins with widespread expression patterns, localizing in the SCN 
as well as many peripheral tissues (Tei et al., 1997; Albrecht et al., 1997; Shearman et al., 
1997; Zylka et al., 1998; Shigeyoshi et al., 1997).  Mice deficient in mPer1 have a persistent 
circadian rhythm with a shortened period; these mice also show impaired ability to maintain 
precision and stability of the circadian period (Zheng et al., 2001).  Mice carrying a 
homozygous mutation in mPer2 display a similarly short period, with complete loss of 
circadian rhythmicity in constant darkness (Zheng et al., 1999).  In contrast, mice deficient in 
mPer3 display an essentially normal circadian clock with a slightly shortened period 
(Shearman et al., 2000a; Reppert and Weaver, 2002).  Taken together, these studies suggest 
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that PER2 is the most critical clock component of the PER proteins, while PER3 is 
considered to be outside the core circadian clockwork (Bae et al., 2001).  A genetic variant in 
human Per2 was the first mutation identified as a cause of familial advanced sleep-phase 
syndrome (Toh et al., 2001).  Expression of PER oscillates with the highest amplitude of the 
core clock proteins.   
 PER proteins have been shown to function in the nucleus but do not directly bind to 
DNA (Fu et al., 2002).  In Drosophila, dPER is one of the two main negative regulators of 
dCLOCK-CYC (the other being dTIM) (Wijnen and Young, 2006; Lee et al., 1999).  
Although mammalian PER has been reported to associate with CRY to negatively regulate 
CLOCK-BMAL1, it is widely accepted that CRY is the more potent circadian repressor in 
mammals (Reppert and Weaver 2002; Yu and Hardin, 2006).  PER2 can suppress 
transcription by NPAS2-BMAL1 (a circadian transcriptional activator complex similar to 
CLOCK-BMAL1) as shown by reporter gene assay (Fu et al., 2002).  Studies suggest that, in 
addition to its repressor function, PER2 also acts as a positive regulator, stimulating 
transcription of BMAL1 (Shearman et al., 2000).  The NONO and WDR5 proteins, which 
associate with PER1, have been shown to modulate PER function:  NONO likely functions 
as an antagonist to PER, while WDR5 appears to assist PER function (Brown et al., 2005).  
Stability of PER2 appears to be dependent, either directly or indirectly, on mCRY, as mPER2 
protein levels in the SCN are markedly reduced in Cry1-/-Cry2-/- animals (Shearman et al., 
2000).   
 PER1 and PER2 may also function in the cell cycle.  mPer2m/m mice were found to be 
hypersensitive to ionizing radiation, and thymocytes from these mice fail to undergo cell 
cycle arrest or apoptosis after exposure to IR.  Additionally, IR was shown to cause an 
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increase in transcription of mPer1, mPer2, Clock, Cry1, and Bmal1 (Fu et al., 2002).  
Overexpression of mPer2 induces apoptosis in cancer cell lines and alters the expression of 
apoptosis-related genes (Hua et al., 2006).  PER1 has also been linked to the cell cycle 
through interaction with checkpoint proteins ATM and Chk2.  Overexpression of Per1 
sensitizes cancer cells to apoptosis after exposure to IR.  In contrast, inhibition of Per1 
expression by siRNA causes a marked decrease in IR-induced apoptosis (Gery et al., 2006).  
Together, these data suggest that the PER family of proteins plays a role in the cell cycle, 
though it is unknown whether or not this function is independent of PER’s circadian clock 
role.   
CRYPTOCHROME 
 CRYPTOCHROME was originally identified as a plant blue-light photoreceptor 
which was especially important in cryptogamic plants and possessed a “cryptic” nature 
(Ahmad and Cashmore, 1993; Sancar, 2000).   The first Cryptochrome gene isolated was 
from the mustard plant and was at first thought to be a photolyase (Batschauer, 1993).   
CRYs belong to the photolyase/cryptochrome family of structurally analogous flavoproteins, 
having high structural and sequence similarity to DNA photolyase.  DNA photolyase, present 
in prokaryotes and lower eukaryotes but missing in humans, is a repair enzyme which utilizes 
blue light to repair UV-damaged DNA (Rupert et al., 1958; Sancar, 1994).  
CRYPTOCHROMEs, while having high similarity to DNA photolyase, by definition exhibit 
no repair activity (Sancar, 2000).  Rather, plant CRYs use blue light to regulate growth and 
adaptation to the environment, while animal CRYs entrain the circadian clock to the daily 
light-dark cycle.  CRY possesses a region of very high structural homology to photolyase, 
called the photolyase homology region (PHR) and most CRYs, especially those found in 
 11
eukaryotes, have a C-terminal extension whose sequence varies widely (Sancar, 2000;  
Partch and Sancar, 2005).  This C-terminal extension is largely unstructured and is thought to 
be important in regulating CRY activity through a signal transduction cascade.  In humans, 
CRY1 and CRY2 share a high amount of homology (80%) but have highly divergent C-
terminal extensions.  CRY1 also contains a well-conserved nuclear localization signal in its 
C-terminal extension whose deletion abrogates its translocation into the nucleus (Chaves et 
al., 2006).  Both photolyases and CRYs contain two covalently-bound chromophores; most 
commonly, these are 5,10-methenyltetrahydrofolate (MTHF) and flavin adenine dinucleotide 
(FAD) (Sancar, 2003).  MTHF acts as a photoantenna, absorbing a photon of blue light 
(Sancar, 2003; Johnson et al., 1988) while FAD is the catalytic chromophore, facilitating 
electron transfer (Kao et al. 2005; Saxena et al., 2005).  Mammalian CRY uses its bound 
chromophores to function as a circadian photoreceptor in the SCN, absorbing blue light to 
entrain the circadian clock.  CRY may also, as in plants, act as a mammalian blue-light 
photoreceptor (Sancar, 2000).   
Role of CRYPTOCHROME in the Circadian Clock  
The CRY proteins are essential to the mammalian circadian clock (Sancar, 2000; 
Kume et al., 1999; van der Horst et al., 1999).  Cry mutant animals show seemingly normal 
circadian behavior under a 12 hour light:12 hour dark (LD 12:12) regimen; however, this 
behavior is masking caused by visual light perception (Sancar, 2000).  Under constant 
darkness, normal animals should exhibit their endogenous circadian period; it is under these 
conditions that the phenotype of circadian mutant animals is most apparent.  Deletion of 
mCry1 results in a shortened circadian period in constant darkness (van der Horst et al., 
1999).  In contrast, deletion of mCry2 lengthens the circadian period (Thresher et al., 1998; 
 12
van der Horst et al., 1999).  mCRY1 and mCRY2, therefore, are necessary to maintain 
normal circadian periodicity.  Mice deficient in both mCry1 and mCry2 show complete loss 
of circadian rhythmicity in constant darkness (van der Horst et al., 1999; Sancar, 2000).   
With regard to clock gene expression, induction of Per1 expression is severely blunted in 
both Cry1-/- and Cry2-/- mice; however, in the double Cry1-/-Cry2-/- knockout Per1 is 
expressed at high, non-oscillating levels with no induction after light pulses (Sancar, 2000).  
Interestingly, in both Cry1-/- and Cry1-/-Cry2-/- mice Per2 continues to oscillate, with a higher 
amplitude than that seen in wild-type mice (Vitaterna et al., 1999), with overall high levels of 
gene expression.  Therefore there appears to be a CRY-independent pathway for Per2 
expression.  Although Per transcript levels are high, PER protein levels in Cry mutant 
animals are low, suggesting that CRY plays a role in PER protein stability.  In constant 
darkness, neither Per1 nor Per2 expression are oscillatory in Cry1-/-Cry2-/- mice (Sancar, 
2000), consistent with their arrhythmic behavior under such conditions.  The status of Per1 
and Per2 expression in the Cry mutant animals is consistent with a role of CRY in negative 
regulation of Per expression.   
Indeed, CRY has been determined to be the main negative regulator of the 
mammalian CLOCK-BMAL1 transcriptional activator complex, effectively “closing” the 
clock feedback loop (Kume et al., 1999; Sancar, 2000).  After CLOCK-BMAL1-mediated 
transcription of the Per and Cry genes, PER and CRY proteins are translated in the 
cytoplasm and form complexes which translocate into the nucleus and downregulate 
CLOCK-BMAL1-driven transcription (Sancar, 2000).  Both CRY1 and CRY2 have been 
shown to strongly inhibit CLOCK-BMAL1-mediated transcription (Griffin et al., 1999; 
 13
Kume et al., 1999; Okamura et al., 1999).  In this way, CRY proteins negatively regulate 
their own transcription, along with that of Per and other CCGs.   
Interactions of CRYPTOCHROME with other Clock Proteins 
 Mammalian CRY has been shown to interact with a number of proteins.  Yeast two-
hybrid screens and co-immunoprecipitation experiments have shown interactions of CRY 
with BMAL1, CLOCK, PER1, PER2, PER3, and TIM (Griffin et al., 1999, Shearman et al., 
1999, Sancar, 2000).  CRY’s interaction with CLOCK and BMAL1 is likely important for its 
repressor function; recently CLOCK and BMAL1 mutants were identified which are resistant 
to CRY-mediated repression (Sato et al., 2006).  These mutants also showed decreased 
interaction with CRY and, to a lesser extent, PER.  CRY’s interaction with PER is thought to 
be important for PER protein stability and translocation into the nucleus (Kume et al., 1999).  
Clock proteins have been found to form large, time-specific multimeric complexes (Lee et 
al., 2001) including CLOCK, BMAL1, PER1, PER2, CRY1, CRY2, and CK1ε.  A yeast 
two-hybrid screen of CRY2 detected protein phosphatase 5 (PP5) as an interacting protein 
(Zhao and Sancar, 1997).  This protein is a serine/threonine kinase which was subsequently 
shown to regulate activity of CK1ε; this regulation is modulated by CRY (Partch et al., 
2006).   
Evolution of CRYPTOCHROME in Animals 
 Other animal systems with proteins homologous to mammalian CRY include 
Drosophila, Xenopus, zebrafish, monarch butterfly, honeybee, bumblebee, red flour beetle, 
and mosquito (Yuan et al., 2007; Reppert 2006).  By phylogenetic analysis, Cryptochrome 
evolution appears to have given rise to two Cry genes in insects, now thought to represent the 
basal animal Cry lineage.   This is a novel viewpoint because until recently the Drosophila 
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circadian system, about which the most is currently known, was thought to represent the 
basal evolutionary lineage.  Drosophila contains only one Cry gene (dCry) which is a known 
photoreceptor to entrain the circadian clock; however, it is not required for circadian 
behavioral rhythms (Stanewsky et al., 1998; Helfrich-Forster et al., 2001).  dCRY has 
traditionally not been considered a transcriptional repressor; however, recent work has shown 
that it can indeed repress CLOCK-CYCLE in cell culture (Collins et al., 2006).  One 
important feature of dCRY is that it is degraded by light (Lin et al., 2001).  Although 
Drosophila expresses only one CRY protein, other insects including the mosquito and 
monarch butterfly express two CRY proteins, one with homology to dCRY and one with 
homology to mammalian-like CRYs (Zhu et al., 2005).  Monarch butterfly CRY1, similar to 
dCRY1, is degraded by light; monarch butterfly CRY2, similar to mCRYs, can act as a 
circadian transcriptional repressor (Zhu et al., 2005).  Other insects, including the honey bee 
and red flour beetle, contain only a mammalian-like CRY (Zhu et al., 2005; Rubin et al., 
2006).  A new model of CRY evolution has emerged, suggesting that the mosquito and 
butterfly and those organisms having both types of CRY represent the ancestral insect 
lineage, and Drosophila diverged to retain only one CRY primarily acting as a photoreceptor 
and other insects diverged with only a mammalian-like CRY acting as a transcriptional 
repressor (Yuan et al., 2007).   
Other Circadian Clock Proteins 
 In addition to the core clock components, there are other proteins that participate in 
the mammalian circadian mechanism.  These are Casein Kinase 1ε (CK1ε), REV-ERBα, 
RORα, NPAS2, Protein Phosphatase 5 (PP5), and Timeless (TIM).  I will provide a brief 
description of these proteins here. 
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Casein Kinase 1ε (CK1ε) 
 CK1ε is a kinase homologous to the DOUBLETIME kinase in Drosophila.  CK1ε has 
been shown to phosphorylate PER proteins, which results in their ubiquitin-dependent 
degradation (Akashi et al., 2002).  CK1ε can also phosphorylate CRY1, CRY2, and BMAL1 
in vitro (Eide et al., 2002; Akashi et al., 2002).  Although cellular levels of CK1ε do not 
appear to oscillate, its subcellular localization does appear to be circadian-dependent (Lee et 
al., 2001).  Additionally, it has been found in a large complex of clock proteins whose 
formation is time-dependent.  As post-translational modifications are becoming increasingly 
important components of the mammalian clock model, CK1ε’s circadian function is of great 
interest.  A second related kinase, CK1δ, with high homology to CK1ε has been shown to 
display similar properties and is likely also a modulator of clock proteins.  Activity of both 
CK1ε and CK1δ is tightly regulated by inhibitory autophosphorylation (Gietzen and Virshup, 
1999) and the protein phosphatase PP5 has been indicated as having a role in this process 
(Partch et al., 2006).   
REV-ERBα and RORα 
 REV-ERBα and RORα are both orphan nuclear receptor proteins.  These proteins 
both participate in regulation of expression of Bmal1, in a second mammalian feedback loop.  
Both the Rev-Erbα and Rorα genes are targets of CLOCK-BMAL1 transcriptional activation; 
their gene products REV-ERBα and RORα subsequently regulate Bmal1 expression by 
repression (REV-ERBα) or activation (RORα) (Preitner et al., 2002; Ueda et al., 2002).   
NPAS2 
 The Npas2 gene encodes a functional analog of CLOCK which can heterodimerize 
with BMAL1 and activate clock gene expression off of E-box promoters (Reick et al., 2001;  
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Hogenesch et al., 1998).  However, the expression profile of Npas2 differs in that it is most 
highly expressed in the brain.  NPAS2 has been shown to contain a bound heme cofactor 
which renders the DNA-binding activity of NPAS2-BMAL1 sensitive to CO gas; in this way, 
NPAS2 may couple the circadian clock to the heme metabolic cycle (Dioum et al., 2002).  
NPAS2 may also couple the circadian cycle to cellular redox rhythms.  NPAS2 is thought to 
bind nicotinamide adenine dinucleotide (NAD) through its bHLH domain (Wijnen and 
Young, 2006) and the DNA-binding of NPAS2-BMAL1 can be modulated by NAD in vitro 
(Rutter et al., 2001).  This could be especially important in circadian entrainment through 
feeding, which induces changes in cellular NAD concentrations (Damiola et al., 2000).  
NPAS2 has also been proposed as a candidate redundant protein to CLOCK which, in the 
absence of CLOCK, helps to maintain circadian rhythmicity in the SCN.  Clock-/- mice were 
recently found to maintain circadian cycling, suggesting a redundant factor; however Npas2 
RNA is undetectable in the SCN (DeBruyne et al., 2006).  The ability of NPAS2 to 
compensate in the absence of CLOCK is, therefore, of great interest.   
Protein Phosphatase 5 (PP5) 
 PP5 is a serine-threonine kinase that is expressed in both the SCN and peripheral 
tissues in a non-oscillating fashion (Partch et al., 2006).  Outside of the circadian clock, PP5 
has been implicated in cell cycle by interaction with and regulation of DNA-PKcs (Wechsler 
et al., 2004), regulation of p53 function (Zuo et al., 1998), and dephosphorylation of the 
proapoptotic protein ASK1 (Morita et al., 2001).  PP5 interacts with CRY1 and CRY2 and 
this interaction inhibits PP5 activity (Zhao and Sancar, 1997).  PP5 can also interact with 
CK1ε both in vitro and in vivo, regulating its activity in both cases (Partch et al., 2006); CRY 
noncompetitively modulates this process.  PP5 is emerging as an important component of the 
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mammalian circadian clock, as a result of its interactions with clock proteins and the finding 
that knockdown of PP5 by shRNA impairs circadian cycling in cultured cells (Partch et al., 
2006).     
Timeless (TIM) 
 The inclusion of mammalian TIM in the cadre of circadian clock proteins has been 
controversial (Barnes et al., 2003; Albrecht, 2002).  Deletion of mTim results in an 
embryonic lethal phenotype (Gotter et al., 2000); as this has not been observed for any other 
bona fide clock protein, many took this as evidence that mTim, although partially 
homologous to Drosophila clock gene dTim, does not belong to the group of mammalian 
core clock genes.   However, more recent data contradicts this finding, reporting that 
conditional knockdown of mTim expression in the SCN disrupts activity rhythms and alters 
the expression levels of clock proteins (Barnes et al., 2003).  In this report, mTim expression 
was found to oscillate with 24-hour periodicity.  In addition to interacting with CRY2, TIM 
has been shown to interact with the DNA damage checkpoint proteins CHK1 and ATR-
ATRIP, and that its expression oscillates also with the cell cycle (Unsal-Kacmaz et al., 2005).  
Knockdown of mTim expression by siRNA abrogates CHK1 phosphorylation after 
hydroxyurea treatment and results in premature chromatin condensation (PCC).  These data 
have led to the proposal of TIM as one of the components that couples the cell cycle to the 
circadian cycle; this relationship is of great interest, especially with regard to the involvement 
of circadian rhythm disruption with cancer predisposition (Gauger and Sancar, 2005; 
discussed in detail in Chapter 2). 
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Circadian Clocks in Other Organisms 
 Other than mammals, the circadian clock systems of cyanobacteria, Neurospora 
crassa, Arabidopsis thaliana, and Drosophila melanogaster have been the best characterized.  
I will provide a brief summary of these systems here.   
Cyanobacteria 
 The cyanobacterium Synechococcus elongatus displays a clear circadian rhythm that 
profoundly affects its cellular metabolism (Liu et al., 1995).  The cyanobacterial core 
oscillator consists of a complex of the KaiA, KaiB, and KaiC proteins (reviewed in Iwasaki 
and Kondo, 2004).  KaiC protein can autophosphorylate; this action is enhanced by KaiA and 
antagonized by KaiB.  The cyanobacteria clock was at first thought to consist of a 
transcription-translation-derived oscillatory feedback loop, similar to that which has been 
proposed in the mammalian clock, which does not regulate a specific set of clock-controlled 
genes but rather regulates genome-wide gene expression (Nakahira et al., 2004).  In this 
model, the core loop revolves around the expression of the kaiBC operon (Wijnen and 
Young, 2006).  KaiA enhances expression of kaiBC, forming the positive segment of the 
feedback loop.  KaiC represses its own (kaiBC) expression, forming the negative segment of 
the feedback loop.  Kai proteins exhibit robust circadian patterns of accumulation, synthesis, 
degradation, localization, and phosphorylation (Kageyama et al., 2006).  Phosphorylation in 
particular is integral to the cyanobacterial clock, as mutation of KaiC’s phosphorylation sites 
abolishes circadian rhythmicity (Nishiwaki et al., 2004).  The canonical cyanobacterial clock 
TTFL model would require transcription and translation for oscillation to occur.  However, 
recently clock oscillation has been reconstituted with the Kai proteins in a closed system, in 
which cyclic phosphorylation of KaiC occurred in vitro after mixing the three Kai proteins 
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with ATP (Kageyama et al., 2006).  Because this oscillation occurred in the absence of 
transcription/translation, the canonical clock model in cyanobacteria has been reevaluated.  A 
new model was proposed in which, over time, KaiA associates with KaiC, resulting in KaiC 
phosphorylation; KaiB then associates with phosphorylated KaiC, inactivating KaiA and 
resulting in KaiC dephosphorylation; KaiB subsequently dissociates from KaiC and the cycle 
begins again (Kageyama et al., 2006).  These findings support the theory that in many 
systems, the TTFL is not solely responsible for circadian cycling and many of the well-
characterized clock models are now undergoing a reevaluation.   
Neurospora crassa 
 Similar to other systems, a TTFL is at the core of the filamentous fungus Neurospora 
crassa circadian clock mechanism.  The positive arm of the feedback loop in this system is 
engendered by the transcription factor White-Collar Complex (WCC), consisting of PAS 
proteins White Collar-1 (WC-1) and White Collar-2 (WC-2) proteins.  The negative arm of 
the feedback loop involves the Frequency (FRQ) protein, which negatively regulates WCC 
activity.  The Frequency gene, frq, is a transcriptional target of WCC; therefore FRQ 
regulates its own expression (Wijnen and Young 2006).  FRQ also participates in the positive 
arm of the feedback loop, helping to assemble the WCC complex in the cytoplasm (Cheng et 
al., 2001).  Post-translational modification, especially phosphorylation, is also important in 
this system.  Hypophosphorylated nuclear FRQ stimulates phosphorylation of WCC, 
inhibiting WCC’s transcriptional activity.  Hyperphosphorylated FRQ accumulates in the 
cytoplasm over the course of the day, which promotes WCC complex assembly.  
Phosphorylation of FRQ also leads to its degradation (Wijnen and Young 2006).   Light 
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response in Neurospora is mediated by the WC-1 protein, which is a blue-light photoreceptor 
(Froehlich et al., 2002).   
Arabidopsis thaliana 
 In plants, circadian rhythms regulate many processes including photomorphogenic 
growth, chloroplast localization, hypocotyls growth, stomata opening, and flowering time.  
The most well-characterized plant circadian clock is in the model organism Arabidopsis 
thaliana.  Again, a set of transcriptional feedback loops governs this clock mechanism.  The 
DNA-binding proteins LHY, CCA1, and LUX participate in the positive feedback loop, 
activating transcription of a number of genes including the PRR5/7/9 genes (activated by 
LHY and CCA1), LHY, and CCA1 (both activated by LUX).  Also involved in positive 
regulation of transcription are the ELF4, GI, and TOC1 proteins.  In turn, PRR5/7/9 and 
ELF3 repress transcription of the LHY and CCA1 genes.  The CK2 protein regulates CCA1 
activity through phosphorylation.  In this way, CK2 inhibits transcription of not only 
PRR5/7/9 but also the ELF3, GI, LUX, ELF4, and TOC1 genes. Photic input in the 
Arabidopsis system is signaled by the ZTL and CRY proteins, which absorb blue light, and 
PHY, which absorbs red light.  CRY does not participate in negative regulation in this 
organism; rather, it acts exclusively as a blue light photoreceptor.  (reviewed in Wijnen and 
Young, 2006) 
Drosophila melanogaster 
 The best-studied insect circadian system is that of Drosophila melanogaster, although 
with the discovery of both insect-like and animal-like CRY proteins in other insect systems 
such as the monarch butterfly (Yuan et al., 2007), it is likely that we will soon know much 
more about the clock mechanisms of other insects.  The Drosophila clock is thought to be 
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engendered by two feedback loops systems.  The first loop is somewhat similar to that of 
mammals:  a transcriptional activation complex comprised of the bHLH-PAS proteins 
CLOCK and CYCLE (CYC) induces rhythmic transcription of target genes including clock 
negative regulators dPer and dTim (Wijnen and Young, 2006).  PER and TIM, in turn, act in 
complex as the main repressors of CLOCK-CYC in the Drosophila system, inhibiting their 
own transcription.  The DOUBLETIME (DBT) protein (homologous to mammalian CK1ε) 
modulates subcellular localization of PER, resulting in its degradation.  In the second 
feedback loop of this system, the CLOCK-CYC heterodimer activates transcription of the 
Pdp1 and Vri genes, whose gene products PDP1 and VRI act as positive (PDP1) and negative 
(VRI) regulators, respectively, of expression of the Clock and Cry genes (Wijnen and Young, 
2006).  The major difference between the mammalian and Drosophila circadian systems is 
the function of CRY (Collins et al., 2006).  While mammalian CRYs are core clock 
components that repress gene transcription and are required for circadian rhythmicity (van 
der Horst et al., 1999; Sancar, 2000), dCRY is not required for maintenance of behavioral 
circadian rhythms in Drosophila (Stanewsky et al., 1998).  Rather, the function of dCRY has 
been suggested to be primarily as a blue-light photoreceptor that entrains the circadian clock 
and targets TIM for light-dependent degradation (Wijnen and Young, 2006).  However, a 
recent report showed that dCRY can repress CLOCK-CYC activity in cell culture, appearing 
to be confined to peripheral clocks (Collins et al., 2006).  This suggests that part of dCRY’s 
function is similar to that of mCRY.   
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Conclusion 
 Although much work has been done to elucidate the mechanisms underlying the 
mammalian circadian clock, many questions still remain.  Microarray studies indicate that a 
large number of cellular genes are potentially under circadian control, and the effect of this 
extensive gene regulation on cellular processes is likely to be far-reaching.  In particular, 
recent studies demonstrating the involvement of circadian genes with cancer development is 
a field of growing importance.  In Chapter 2, I will describe my endeavors to determine the 
effect of Cryptochrome loss on tumor predisposition and DNA damage checkpoint status in 
mice.  Another, more basic, question is the mechanism by which CRY negatively regulates 
CLOCK-BMAL1.  Genetic evidence shows that CRY can inhibit CLOCK-BMAL1, as do 
reporter gene assays; however, without biochemical characterization the molecular 
mechanism by which this occurs cannot be determined.  In Chapter 3, I will describe 
experiments done to determine the validity of one theory of how CRY inhibits CLOCK-
BMAL1.  Together, the experiments described here give important information to increase 
our knowledge of the physiological role(s) of mammalian CRYPTOCHROME.  
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Figure 1.1.   Model for Circadian Clock in Mammals.  CLOCK and BMAL1 are 
transcriptional activators that make up the CLOCK-BMAL1 complex, which activates the 
transcription of Cry, Per, and Bmal1 genes.  The CRY (CRY1 and CRY2) and PER (PER1 
and PER2) proteins are transcriptional repressors that interfere with the activity of CLOCK-
BMAL1 and downregulate transcription of genes controlled by these factors.  In addition, 
PER stimulates the transcription of Bmal1 by an ill-defined mechanism which is regulated by 
the orphan nuclear receptors RORα and REV-ERBα.  Clock-controlled genes (CCGs), which 
include Wee1 and c- myc, are regulated by the clock proteins but do not affect the activity of 
the clock proteins or the transcription of the clock genes.  Wee1 expression is positively 
regulated by CLOCK-BMAL1 and c-myc expression is repressed by this complex.  Hence, in 
the absence of CRY or PER, Wee1 expression is expected to be upregulated due to lack of 
inhibition of CLOCK-BMAL1 by CRY and PER.  It has been reported that c-myc 
transcription is elevated in Per2 mutant mice because of a reduced level of BMAL1, which 
represses the c-myc promoter.   
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CHAPTER 2 
EFFECT OF CIRCADIAN CLOCK DISRUPTION AND 
CRYPTOCHROME LOSS ON TUMORIGENESIS AND THE 
DNA DAMAGE CHECKPOINT IN MICE1 
 
Summary 
It has been reported that disruption of the circadian clock may lead to increased risk 
of breast cancer in humans and to a high rate of ionizing radiation (IR)-induced tumors and 
mortality in mice.  CRYPTOCHROME1 and 2 proteins are core components of the 
mammalian circadian clock and mice mutated in both genes are arrhythmic.  I tested Cry1-/-
Cry2-/- mice and fibroblasts derived from these mice for radiation-induced cancer and killing, 
and DNA damage checkpoints and killing, respectively.  I find that the mutant mice are 
indistinguishable from the wild-type controls with respect to radiation-induced morbidity and 
mortality.  Similarly, the Cry1-/-Cry2-/- mutant fibroblasts are indistinguishable from the wild-
type controls with respect to their sensitivity to IR and ultraviolet (UV) radiation and IR-
induced DNA damage checkpoint response.  These data suggest that disruption of the 
circadian clock in itself does not compromise mammalian DNA repair and DNA damage 
checkpoints and does not predispose mice to spontaneous and IR-induced cancers.  I 
conclude that the effect of circadian clock disruption on cellular response to DNA damage 
and cancer predisposition in mice may depend on the mechanism by which the clock is 
disrupted.   
1The majority of this chapter was published as:  Gauger M.A. and Sancar A.  (2005)  Cryptochrome, Circadian Cycle, Cell 
Cycle Checkpoints, and Cancer.  Cancer Research 65(15), 6828-34.
Introduction 
 The circadian clock and cell cycle are two global regulatory systems in most 
eukaryotic organisms.  It has been known for some time that disruption of the circadian 
rhythm by genetic or environmental factors causes a variety of disorders in humans, such as 
sleep disturbances, seasonal affective disorder, and jet lag.  Disruption of cell cycle 
regulation causes cancer.  Recent epidemiological studies have raised the possibility that 
disruption of the circadian clock may also increase cancer risk in humans (Stevens, 2005) 
and adversely affect prognosis in cancer patients (Mormont and Levi, 1997).  In particular, it 
was reported that women working night-shift exhibited a significant increase in breast cancer 
risk (Davis et al., 2001; Schernhammer et al., 2001).  Similarly, it was reported that cancer 
patients with altered circadian rhythm had poorer survival relative to patients with normal 
rhythm (Mormont et al., 2000).   
 These epidemiological studies were complemented by studies with mouse model 
systems.  In one study, transplantation of an osteosarcoma or a pancreatic adenocarcinoma 
into mice with ablations to the master circadian clock, the SCN, caused accelerated tumor 
growth rate relative to animals with intact SCN (Filipski et al., 2002).  In a second study, it 
was found that mice that were rendered arrhythmic by repeat 8-hour advance of the light-
dark (LD) cycle every 2 days exhibited faster rates of implanted tumor growth relative to 
control mice maintained under a LD 12h:12h cycle (Filipski et al., 2004). 
 Finally, the circadian rhythm was disrupted in mice by targeted mutations of the core 
clock genes that engender the molecular clock not only in the SCN but in all peripheral 
organs and the effect of this disruption on cell growth and spontaneous and IR-induced tumor 
incidence were analyzed.  The core clock proteins are CLOCK and BMAL1 that act as 
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transcriptional activators of the cryptochrome (Cry), Period (Per), and Bmal1 genes; and the 
CRY1, CRY2, PER1, and PER2 proteins that function as transcriptional repressors of the 
CLOCK-BMAL1-driven genes (Young and Kay, 2001; Reppert and Weaver, 2002) (Figure 
1.1).  The effect of these core clock proteins is modulated by additional proteins such as 
REV-ERBα and CK1ε to generate a rather precise molecular oscillator with approximately 
24-hour periodicity.  This periodicity is transmitted to the clock-controlled genes (CCGs) that 
constitute about 10% of the expressed genes in a given tissue to generate rhythmic outputs at 
the physiological and behavioral levels (Delaunay et al., 2002).  The molecular mechanism of 
the mammalian circadian clock has been elucidated in considerable detail in recent years, 
making it possible to investigate the interfacing of this global regulatory pathway with other 
global regulatory systems, such as cell cycle checkpoints, at a mechanistic level.  One such 
study found that in mice with a Per2 mutation, c-Myc transcription was upregulated and p53 
was downregulated; as a consequence, these animals had increased incidence of spontaneous 
and ionizing radiation (IR)-induced lymphomas and an increased rate of mortality after IR 
(Fu et al., 2002).  Another study reported that in CRYPTOCHROMEless mice, WEE1 anti-
mitotic kinase was elevated and, as a consequence, liver regeneration in these mice following 
partial hepatectomy was delayed relative to wild-type controls (Matsuo et al., 2003).  Finally, 
our laboratory has recently found that the mammalian TIMELESS protein, which is 
considered to be a clock protein according to some studies (Barnes et al., 2003) but not others 
(Gotter et al., 2000), binds to DNA damage checkpoint proteins ATR and CHK1 and is 
essential for the DNA damage checkpoint response (Unsal-Kacmaz et al., 2005).   
 Taken together, the epidemiological data, the data from mouse model systems, and 
that from cell-based assays have led to an emerging consensus that the circadian cycle and 
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cell cycle are tightly coupled and that disruption of the circadian cycle by any means would 
disrupt cell cycle checkpoints as well, causing animals with circadian clock disruption to be 
more prone to spontaneous and DNA damage-induced cancers (Stevens, 2005; Mormont and 
Levi, 1997; Davis et al., 2001; Schernhammer et al., 2001).  Within this conceptual 
framework, then, I wished to examine the effect of circadian clock disruption caused by 
Cryptochrome knockout on DNA damage checkpoints and on predisposition to spontaneous 
and IR-induced cancers.  I find that clock disruption by Cryptochrome knockout does not 
measurably affect DNA damage checkpoints and does not cause mice to be more susceptible 
to cancer.  I conclude that circadian clock disruption per se does not prime cells to cancerous 
transformation, presumably due to the presence of homeostatic mechanisms, in addition to 
the circadian rhythm, that regulate cell cycle and cellular responses to DNA damage.   
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Experimental Procedures 
Mice, IR Treatment, and Survival   
Cry1-/-Cry2-/- mice (Selby et al., 2000; Vitaterna et al., 1999) were backcrossed with 
C57BL/6J six times to obtain Cry mutant mice in essentially the same genetic background as 
wild-type control C57BL/6J mice obtained from the Jackson Laboratory.  The mice were 
maintained on an LD 12:12 schedule under ambient room lighting at an ambient temperature 
of 21-23°C and 50-70% humidity.  For irradiation treatment, a cesium-137 radiation source 
emitting γ-rays at a rate of 0.82 Gy/min was used.  24 wild-type and 27 Cry1-/-Cry2-/- mice 
were treated at 8 weeks of age with a single dose of 4 Gy at zeitgeiber time (ZT) 10.  (By 
convention, ZT0 is the time of lights-on and ZT12 is the time of lights-off.)  For the 
experiment described in Figure 2.6, 8 wild-type (4 males, 4 females) and 8 Cry1-/-Cry2-/- (4 
males, 4 females) mice were treated at approximately 8 weeks of age with 6 Gy of IR at ZT 
10.   
Fibroblast Cell Lines, Growth Rate Measurement, and UV and IR Survival   
Dermal fibroblast cell lines were isolated as described (Thompson et al., 2004) using 
skin biopsies from wild-type and Cry1-/-Cry2-/- mice.  Fibroblasts underwent spontaneous 
immortalization.  Figure 2.1 shows Western blots confirming the loss of CRY1 and CRY2 
protein expression in the Cry1-/-Cry2-/- cell line.   
 Cells were grown in Dulbecco’s Modified Eagle Medium (DMEM; Gibco) 
supplemented with 10% fetal bovine serum (Gemini) and 100 units/ml penicillin and 100 
μg/ml streptomycin (Gibco).  Cells were maintained in an incubator at 37°C under 5% CO2.  
For growth rate measurements, cells were plated in 150mm plates at low density to ensure 
 30
continued proliferation throughout the duration of the experiment.  Cells were trypsinized 
and counted at the indicated timepoints using a hemocytometer. 
 Cell survival to radiation was determined by clonogenic assay.  Wild-type and Cry1-/-
Cry2-/- fibroblasts were plated at low density to ensure the formation of approximately 200 
colonies per 100 mm plate in the absence of radiation treatment.  Following plating, cells 
were incubated in growth medium for 10-14 hours and then treated with either ultraviolet 
(UV) or IR of appropriate doses.  UV treatment at the indicated doses was performed using a 
GE germicidal lamp emitting mainly at 254 nm.  Cells were washed with PBS, irradiated 
with UV at a fluence rate of 0.65 J/m2s in the absence of growth medium, and new growth 
medium was added after treatment.  For IR treatment, cells in growth medium were irradiated 
from a cesium-137 radiation source at a rate of 0.82 Gy/min.  After radiation treatment, cells 
were incubated for 9-10 days until colonies were readily visible.  Cells were fixed for 20 
minutes in 3:1 methanol:acetic acid, rinsed with water, and stained with Giemsa stain.  
Colonies containing 50+ cells were scored.   
Flow Cytometry   
Fibroblasts were grown in DMEM and plated to achieve a density of 1-2 million cells 
at the time of experiment.  Cells were treated with IR as described above.  At the indicated 
time post-treatment, cells were trypsinized and fixed in 70% ethanol.  DNA content analysis 
was performed using propidium iodide staining and a Beckton-Dickinson FACScan 
analytical flow cytometer.  Data acquisition and representation was done with Cicero 
Software (Cytomation, Inc.).  
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Western Blotting   
Standard western blotting procedures were used for CRY1, CRY2, WEE1, c-MYC, 
and BMAL1 proteins from wild-type and Cry mutant mouse liver extracts and fibroblast cell 
lysates.  For some of the western blots we used livers from Cry mutant mice in an rd/rd 
background because of the ready availability of these animals (Thompson et al., 2004).  The 
rd mutation does not affect the molecular clock (Young and Kay, 2001; Reppert and Weaver, 
2002).  Anti-CRY antibodies produced in our laboratory were used to probe for CRY1 and 
CRY2 proteins.  Anti-WEE1 rabbit polyclonal antibody (H-300, Santa Cruz Biotechnology) 
and anti-cMYC mouse monoclonal antibody (9E10, Santa Cruz Biotechnology) were used to 
probe for WEE1 and c-MYC, respectively.  Anti-BMAL1 guinea pig polyclonal antibody 
(Lee et al., 2001) was a kind gift of Dr. Choogon Lee (Florida State University).  Anti-IgG 
rabbit and mouse antibodies (Amersham Pharmaceuticals) and anti-IgG guinea pig antibodies 
(Jackson Immunoresearch Laboratories) were used for secondary antibody blotting. 
 
 
 
 
 
 
 
 
 
 
 32
Results 
Expression of BMAL1, WEE1, and c-MYC in Cryptochromeless Mice and Fibroblasts  
In the conventional clock model, CLOCK and BMAL1 constitute the positive 
regulatory branch while the CRYs and PERs make up the negative branch of the 
autoregulatory oscillatory circuit (Figure 1.1).  In addition, CRYs and PERs appear to 
stimulate transcription of BMAL1 by an ill-defined mechanism (Young and Kay, 2001; 
Reppert and Weaver, 2002).  As a consequence, Per and Cry mutants often exhibit similar 
molecular and behavioral phenotypes.  However, it must be noted that there are subtle but 
significant differences between Cry and Per mutant mice.  Hence, it is not possible to predict 
the responses of Cry or Per mutant cells and mice to a certain treatment based on responses 
observed with their Per or Cry mutant counterparts, respectively. 
 Recently, it was reported that in Cry mutant mice, the level of anti-mitotic WEE1 
kinase was elevated in the liver (Matsuo et al., 2003) and that in Per2 mutant mice, c-Myc 
transcription was upregulated (Fu et al., 2002).  Both genes are CCGs that contain multiple 
E-boxes in their promoters, which are recognized by the CLOCK-BMAL1 complex.  In the 
case of wee1, the binding of CLOCK-BMAL1 to the promoter stimulates transcription; in the 
case of c-Myc, binding of the heterodimer (or of the CLOCK-NPAS2 complex) inhibits 
transcription.  The elevation of WEE1 in the Cry mutant was ascribed to the lack of 
inhibition of CLOCK-BMAL1 by CRY (Matsuo et al., 2003; Oishi et al., 2003).  
Upregulation of c-Myc transcription in the Per2 mutant was ascribed to the reduced level of 
BMAL1 because PER2, in addition to its inhibitory effect on the CLOCK-BMAL1 complex, 
stimulates transcription of the Bmal1 gene (Fu et al., 2002, Hogenesch et al., 2003, Shearman 
et al., 2000).  Thus, to begin to investigate the effect of cryptochrome knockout on cellular 
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and organismic response to DNA damage, I wished first to determine the expression of 
BMAL1, c-MYC, and WEE1 in Cry mutant mice and fibroblasts.  Loss of expression of both 
CRY1 and CRY2 proteins in knockout mice and derived fibroblasts was confirmed by 
Western blotting (Figure 2.1).   
BMAL1 is expressed very highly and at comparable levels in wild-type and Cry 
mutant fibroblasts (Figure 2.2 A).  However, in comparing BMAL1 expression in the liver, I 
find that BMAL1 is expressed with a circadian periodicity in wild-type liver, but at a reduced 
and non-oscillating level in the Cry mutant (Figure 2.2 B), in agreement with a previous 
report (Lee et al., 2001).  The level of c-MYC has not been previously analyzed in Cry 
mutant mice.  However, it was reported that c-Myc transcription is upregulated in Per2 
mutant mice, presumably due to a reduced BMAL1 level (Fu et al., 2002).  Since BMAL1 is 
reduced in the Cry mutant, I expected to observe elevated c-MYC levels in Cry mutant mice 
and possibly fibroblasts as well.  Figure 2.2 C, D shows that c-MYC is expressed in mutant 
and wild-type fibroblasts at comparable levels and at statistically indistinguishable and non-
oscillating levels in the livers of mutant and wild-type mice.  These results differ from those 
of the previous study, which reported that reduction in BMAL1 levels as a consequence of 
Per2 mutation causes a substantial increase in c-MYC activity (Fu et al., 2002).  However, in 
that study the c-Myc RNA, but not protein level, was measured.  Regardless the cause of the 
discrepancy between the two studies it appears that a decrease in the BMAL1 transcriptional 
regulator does not necessarily lead to increased c-MYC protein in the mouse liver or 
fibroblasts. 
Because it has been reported that CRY and PER regulate Wee1 (Matsuo et al., 2003) 
and c-Myc transcription through their effects on BMAL1 activity and Bmal1 transcription, 
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respectively, I reasoned that the reduced BMAL1 in the Cry mutant would be accompanied 
by elevated WEE1. Figure 2.3 A, B shows that WEE1 is indeed elevated in Cry mutant 
fibroblasts and liver, respectively, relative to the wild-type control and the moderately 
elevated (relative to the low level of WEE1 in wild-type mice) WEE1 in Cry mutant liver 
does not oscillate, in agreement with previous reports (Matsuo et al., 2003; Oishi et al., 
2003).   
DNA Damage Checkpoints and DNA Repair in CRYPTOCHROMEless Fibroblasts 
 WEE1 is a cell cycle kinase that plays a key role in the G2/M transition.  Ongoing 
DNA replication or the presence of DNA damage activate WEE1, which then phosphorylates 
Y14 of the CDC2 mitotic kinase, causing its inactivation and delay of mitosis or arrest of the 
cell cycle at the G2/M interface (Nyberg et al., 2002; Sancar et al., 2004).  It is conceivable 
that elevated WEE1 in Cry mutant mice phosphorylates CDC2 at an increased rate even in 
non-stressed cells, slowing down the G2/M transition and the overall growth rate.  Indeed, it 
was reported that 3 days after partial hepatectomy the regenerating liver of 
CRYPTOCHROMEless mice contained fewer mitotic figures and lagged in weight recovery 
by about 15% relative to the wild-type control (Matsuo et al., 2003).  Based on these 
considerations, then, I expected CRYPTOCHROMEless fibroblasts to grow more slowly 
than wild-type fibroblasts and to arrest for a longer period at the G2/M boundary after DNA 
damage, possibly remaining at this interface indefinitely and thus undergoing replicative 
death.  Interestingly, I did not observe either of these two effects.  First, 
CRYPTOCHROMEless fibroblasts grew at a rate indistinguishable from wild-type 
fibroblasts under standard growth conditions (Figure 2.3 C).  Second, and more importantly, 
after 8 Gy of IR the CRYPTOCHROMEless fibroblasts appear to arrest at the G2-M and to 
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recover from this arrest at the same rate as wild-type fibroblasts (Table 2.1).  It is likely that 
multiple factors contribute to the difference between the reported effect of CRY on liver 
regeneration rate and our results with tissue culture.  It is also possible that the tissue culture 
conditions do not possess the requisite sensitivity to detect a 15% difference in growth rate.  
Regardless of these considerations, however, it is safe to conclude that the approximately 3-
fold increase in WEE1 level in CRYPTOCHROMEless cells does not cause a comparable 
decrease in cell growth rate and it has no detectable effect on the DNA damage checkpoint 
response.   
 As a further test of DNA damage checkpoint response in the absence of a functional 
clock, I determined the survival of CRYPTOCHROMEless fibroblasts to ultraviolet and 
ionizing radiation.  Figure 2.4 shows that the Cry mutant is indistinguishable from wild-type 
in its response to both genotoxicants.  As most checkpoint defects increase cellular sensitivity 
to genotoxicants (Nyberg et al., 2002; Sancar et al., 2004) these results further confirm the 
conclusion based on Table 1 that, in the absence of CRY, DNA damage checkpoints are 
normal.  Of equal significance, the data in Figure 4 also reveals that nucleotide excision 
repair (as measured by UV resistance) and double-strand break repair (as measured by 
resistance to IR) are unaffected by loss of the clock.  Thus, I conclude that, in the absence of 
a circadian clock, both DNA damage checkpoints and the two major DNA repair pathways 
for repairing base damage and backbone breaks operate essentially normally.   
IR-induced Morbidity and Mortality in CRYPTOCHROMEless/Clockless Mice   
Per2 mutant mice lack circadian rhythm and were reported to be more sensitive to the 
acute and chronic effects of ionizing radiation relative to wild-type controls (Fu et al., 2002).  
The acute effects included hair graying, hair loss, and skin ulcerations.  Chronic effects were 
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an approximately 10-fold increase in incidence of lymphomas relative to wild-type controls 
and a comparable increase in mortality within 70 weeks following treatment with 4 Gy of IR.  
The increased incidence of lymphomas and higher mortality rate were ascribed in part to the 
elevated c-Myc and in part to a general dysregulation of cell cycle genes as a result of clock 
disruption. 
 To determine whether or not clock disruption by any means has similar effects on IR-
induced morbidity and mortality, I irradiated 8-week old Cry1-/-Cry2-/- mice and wild-type 
controls with 4 Gy of IR at ZT10 and followed their survival for 90 weeks.  The results 
obtained differed from those obtained with Per2 mutant mice.  First, I did not observe a 
difference in the timing and intensity of hair graying and loss between Cry mutant and wild-
type mice (data not shown).  Second, and most significantly, over the 90-week observation 
period there was no significant difference in the mortality of irradiated Cry mutant mice and 
wild-type mice (Figure 2.5).  Moreover, in contrast to the similarly treated Per2 mutant mice, 
I did not detect overt lymphomas in irradiated Cry mutant animals.  The irradiated mice died 
from a variety of causes including genitourinary prolapses and infections, paralysis, and 
seizures that necessitated euthanasia, and in some cases from indeterminable causes.  
Importantly, however, there was no detectable difference between the causes of death of 
CRYPTOCHROMEless and wild-type animals.  These results suggest that clock disruption 
per se does not make mice hypersensitive to the acute effects of IR, nor does it predispose 
them to increased incidence of spontaneous of IR-induced cancers or mortality from any 
other cause.  The significance of these findings is discussed in detail in the Discussion 
section.   
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 In addition to examining the chronic effects of IR on mice, I was also interested in the 
acute effects of IR in wild-type and Cry1-/-Cry2-/- animals.  A small cohort of wild-type (8; 4 
males and 4 females) and Cry1-/-Cry2-/- (8; 4 males and 4 females) were irradiated with a 
higher dose of 6 Gy IR at 8 weeks of age at ZT 10.  Interestingly, I found that there was a 
difference in the acute effects of IR between wild-type and Cry1-/-Cry2-/- mice (Figure 2.6).  
Both male and female wild-type mice showed a strong acute response to IR, displaying a 
high amount of hair graying and/or hair loss.  However, while male Cry1-/-Cry2-/- mice 
showed a similarly strong acute IR response by hair graying and loss (Figure 2.6 A), female 
Cry1-/-Cry2-/- mice were largely unaffected, exhibiting very little if any hair graying or hair 
loss (Figure 2.6 B).  These results, though representative of only a small sample of 
individuals, would indicate that loss of Cry expression could protect against acute response to 
DNA-damaging agents, and that hormonal regulation, which is a primary physiological 
difference between females and males, may play an important role in this function.  This data 
is supported by a recent report by Gorbacheva and colleagues (Gorbacheva et al., 2005), 
showing that Cry1-/-Cry2-/- mice exhibit less morbidity relative to wild-type mice after 
treatment with cyclophosphamide, a chemotherapeutic drug which causes DNA damage by 
alkylation.   
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Discussion 
Circadian Cycle and Cell Cycle   
The circadian cycle and cell cycle are two global regulatory mechanisms that directly 
or indirectly influence all biochemical reactions in cells.  Hence, it is logical to assume that 
disruption of one would cause deregulation of the other with adverse consequences for the 
cell (Bjarnason et al., 2000; Nagoshi et al., 2004; Welsh et al., 2004). Recent advances 
in understanding the circadian clock at the molecular level have provided the opportunity to 
approach the circadian cycle-cell cycle connection from a mechanistic perspective.  Thus, it 
was reported that the core circadian clock machinery affects cell cycle progression in 
proliferating cells by controlling the expression of WEE1, a kinase that regulates the activity 
of CDC2 and hence the G2/M transition (Matsuo et al., 2003).  Another study concluded that 
Per2 mutant mice had constitutively elevated levels of the cell growth/proliferation gene c-
Myc and reduced expression of p53, which plays a critical role in the G1/S checkpoint (Fu et 
al., 2002).  Finally, our laboratory has recently found that the mammalian TIM plays a direct 
role in cell cycle checkpoints including the intra-S and replication checkpoints (Unsal-
Kacmaz et al., 2005).  Although the role of the mammalian TIM in the circadian clock is a 
matter of some debate (Barnes et al., 2003; Gotter et al., 2000), these studies in aggregate 
have given credence to the general view that circadian disruption by whatever means may 
lead to a failure of cell cycle checkpoints (Fu and Lee, 2003).  However, this view needs to 
be critically tested experimentally.  In particular, it remains to be determined if proteins that 
have been presumed to be exclusively clock proteins such as CLOCK and BMAL1, which 
work as partners in the positive branch of the clock, and CRY and PER, which work as 
partners in the negative branch, also perform functions outside of the clock and unique to 
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each protein.  In the case of mammalian TIM, it is clear that the protein participates in cell 
cycle control independent of its role in the clock (Unsal-Kacmaz et al., 2005).  If the so-
called canonical clock proteins CLOCK, BMAL1, CRY, and PER have unique cellular 
functions outside of the clock machinery, then the mutants of these proteins are expected to 
exhibit some unique features as well.  An additional possibility is that different clock mutants 
disturb the circadian cycle in different ways, leaving a different pattern of circadian genes 
“on” and “off” depending on when the clock stops.  Although the molecular clock does not 
“stop” at a given time but rather falls into a stable equilibrium that terminates the cycles in 
the abundance of its components, one can imagine that leaving certain circadian genes “on” 
or “off” might cause a susceptibility to cancer or not, without necessarily making cancer 
susceptibility caused by clock disruption specific to a particular clock gene.  Moreover, cell 
cycle and carcinogenic transformation are also regulated by homeostatic mechanisms and 
therefore a potentially cell cycle-disruptive effect of a clock gene mutation might be 
mitigated or completely alleviated by such compensatory mechanisms.  As a consequence, a 
priori it cannot be known whether all circadian disruptions will have the same effect on cell 
cycle and DNA damage checkpoints and whether their potential cell cycle-disruptive effects 
will necessarily lead to actual disruption. 
Cell Cycle Checkpoints in the Absence of Circadian Rhythm   
In this study I analyzed the growth properties, cell cycle checkpoints, and DNA repair 
capacity of Cry1-/-Cry2-/- fibroblasts and the susceptibility to IR-induced cancer and mortality 
of Cry1-/-Cry2-/- mice.  Based on published reports of Cry and Per mutations on cellular 
growth (Matsuo et al., 2003) and damage response (Fu et al., 2002), I was expecting the Cry 
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mutants to be defective in DNA damage checkpoints and to exhibit increased IR-induced 
morbidity and mortality for the reasons outlined below. 
 First, current clock models presume that CRY and PER function as heterodimers and 
since it has been reported that in Per2 mutant mice, c-Myc is upregulated, p53 is 
downregulated, and there is a general cell cycle dysregulation (Fu et al., 2002), I expected 
that the Cry mutant fibroblasts would exhibit some cell cycle checkpoint defects and that the 
Cry mutant mice, like the Per2 mutants, would be cancer-prone.  I find that in Cry mutant 
livers, BMAL1 expression, as in the case of the Per2 mutant, is reduced.  However, in an 
apparent contrast to the Per2 mutant mice, the c-MYC level is not elevated in either Cry 
fibroblasts or mice, indicating that PERs and CRYs affect c-Myc expression differently.  It 
must be noted, however, that in the Per2 mutant mice the c-Myc RNA, but not the protein 
level, was measured.  It is conceivable that even in the Per2 mutant mice the elevated level 
of c-Myc mRNA is not accompanied by elevated c-MYC protein and that the increased 
incidence of spontaneous and IR-induced lymphomas reported in these animals was caused 
by an unknown effect of PER2 on cell growth and proliferation. 
 Second, it was reported (Matsuo et al., 2003) that WEE1 kinase, which inhibits the 
G2/M transition, is elevated in Cry mutant mice and evidence was presented suggesting that 
after partial hepatectomy, the liver of Cry mutant mice regenerates more slowly than that of 
wild-type controls, presumably because of inhibition of mitosis by elevated WEE1.  In 
agreement with previous reports (Matsuo et al., 2003; Oishi et al., 2003), I find that WEE1 is 
elevated in Cry mutant fibroblasts and liver and other tissues of Cry mutant mice.  However, 
despite this elevation in WEE1 level the Cry mutant fibroblasts grow at a rate 
indistinguishable from the wild-type controls.  It appears that exponentially growing cultures 
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of mutant fibroblasts had fewer mitotic figures than wild-type (data not shown); I assume that 
a slight delay in mitotic entry was compensated by faster progression through other phases of 
the cell cycle such that there was no change in overall growth rate relative to the control.  
Importantly, the mutant cells did not exhibit an amplified checkpoint response to DNA 
damage and, as a consequence, their kinetics of checkpoint-induced inhibition of cell cycle 
progression through G2/M was indistinguishable from wild-type controls.  This again 
indicates the presence of compensatory mechanisms that ensure normal checkpoint response 
even in the presence of elevated WEE1.  These results appear to be contradictory to the 
report indicating slower recovery of liver mass in Cry mutant mice after partial hepatectomy 
(Matsuo et al., 2003).  However, it is possible that the apparent discrepancy may stem from 
differences in stress responses induced by DNA damaging agents, as opposed to partial 
hepatectomy, and the nature of the cell types analyzed in the two studies. 
Circadian Disruption and Cancer Predisposition   
Epidemiological studies have suggested that circadian disruption may contribute to 
cancer incidence (Stevens, 2005) and adversely affect the course of the disease (Mormont 
and Levi, 1997).  A prospective study with Per2 mutant mice appears to have provided a 
molecular explanation for the connection between circadian rhythm disruption and cancer 
predisposition.  My work indicates that disruption of the clock does not necessarily 
predispose mice to cancer.  The cancer predisposition of Per2 mutant mice was ascribed, in 
large part, to decreased BMAL1 expression and the consequent increase in c-Myc expression.  
BMAL1 expression is reduced in both Per2 and Cry mutant mice (Fu et al., 2002; Lee et al., 
2001; this work) and hence it remains to be proven that the increased c-Myc transcription 
reported in Per2 mutant mice is a direct consequence of BMAL1 reduction, which, in the 
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form of either BMAL1-NPAS2 or BMAL1-CLOCK heterodimer, represses c-Myc 
transcription (Fu et al., 2002).  Whatever the cause of elevation of c-Myc transcription in 
Per2 mutants, I do not observe a measurable change in the c-MYC protein level in Cry 
mutant mice and hence it is possible that the absence of PER2 makes mice cancer-prone not 
by overexpression of c-Myc but through an unknown mechanism.  It must be noted, however, 
that the IR-induced mortality of the wild-type mice in our study was the same as that of the 
Cry mutant and, importantly, it was significantly higher than that of the wild-type control 
mice used in the Per2 mutant mouse study.  It is possible that the genetic background 
(C57BL/6J in our study and C57/SV129 in the Per2 study) affects the susceptibility of even 
“wild-type” mice to both IR-induced cancers and IR-induced mortality.  In my study both the 
Cry mutant and the wild-type control mice were in C57BL/6J background and therefore we 
suggest that the lack of difference in morbidity and mortality between the wild-type and Cry 
mutant mice is most likely because circadian clock disruption by eliminating Cry does not 
affect cell cycle checkpoints, DNA repair, or apoptosis in a way that would result in 
increased mutations, reduced apoptosis, and eventually cancer.   
 It should be of interest to find out how mutations in other clock genes, in particular 
Clock and Bmal1, affect the incidence of spontaneous and IR-induced cancers.  A report was 
recently published demonstrating that the sensitivity of mice to the acute effects (weight loss 
and death) of high doses of cyclophosphamide, an alkylating anti-cancer drug, was strongly 
dependent on the circadian time of drug delivery (Gorbacheva et al., 2005) and that the Cry 
mutant used in my study was resistant to the acute effects of cyclophosphamide at all times 
of the day.  Clearly, further studies are needed to explain the apparent resistance of Cry 
mutant mice to the acute effects of cyclophosphamide and, if reproducible, to the acute 
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effects of IR as well as shown by my studies.  Regardless the precise mechanism of the 
resistance, the results of the study on the acute effects of a DNA damaging agent and our 
study on the long-term effects of IR are, in general, in agreement in demonstrating that clock 
disruption per se does not make mice more susceptible to the acute or chronic effects of DNA 
damaging agents. 
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Figure 2.1.   Confirmation of loss of CRY1 and CRY2 proteins in Cry1-/-Cry2-/- mice.  
The figure shows Western blots of (A) cellular lysate from WT and Cry1-/-Cry2-/- (KO) 
fibroblast cell lines and (B) liver extracts from WT and Cry1-/-Cry2-/- (KO) mice.  Protein 
expression was observed using immunoblotting with anti-CRY1 and anti-CRY2 monoclonal 
antibodies.  * denotes the CRY-reactive species. 
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Figure 2.2.   Effect of CRYPTOCHROME on BMAL1 and c-MYC Expression in 
Mouse Fibroblasts and Mouse Liver.  (A and B) BMAL1 expression analysis.  (A) (200 
μg) from wild-type (WT) or Cry mutant fibroblasts were analyzed for BMAL1 expression by 
Western blotting using actin as a loading control.  (B) Liver extracts from wild-type (WT) 
and Cry mutant mice were prepared at the indicated zeitgeiber times (ZT0 = lights on, ZT12 
= lights off) and analyzed for BMAL1 expression using actin as a loading control.  It has 
been reported that in the liver of WT mice, BMAL1 levels are lowest at ZT6 and highest at 
ZT18.  (C and D)  c-MYC expression analysis.  Extracts (200 μg) from fibroblasts (A) or 
mouse liver (B) were probed for c-MYC and actin by Western blotting.  Top, western blot; 
bottom, quantitative analysis of Western blot.  Averages of 3 independent experiments, 
including the one shown in top panel.  Bars indicate standard deviation (n=3).  
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Figure 2.3.   Effect of CRY on WEE1 Expression and Growth Rate of Mouse 
Fibroblasts.  (A and B) WEE1 expression analysis.  Extracts (200 μg) from fibroblasts (A) 
or mouse liver (B) were probed for WEE1 and actin by Western blotting.  Liver extracts were 
prepared at the indicated zeitgeiber times.  (C) Growth kinetics of immortalized fibroblasts 
from wild-type (circle) and Cry1-/-Cry2-/- (triangle) are shown.  Cells were plated at densities 
of approximately 104 cells/dish and cells were counted at the indicated timepoints.  Error bars 
indicate standard deviation (n=3).   
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Figure 2.4.   Radiation Survival of Wild-type and Cryptochrome Mutant Fibroblasts.  
(A) UV survival; (B) IR survival.  Circle, wild-type; triangle, Cry mutant.  Data points are 
averages of 3 independent experiments and the error bars indicate standard deviation (n=3).   
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Figure 2.5. IR survival of wild-type (solid line) and Cry1-/-Cry2-/- (broken line) mice.  
8-week-old mice were exposed to 4 Gy at ZT10 and were observed for 90 weeks.  Survival is 
plotted according to the Kaplan-Meier method.   
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Figure 2.6.   Acute Effect of IR on Wild-type and Cry1-/-Cry2-/- mice.  8-week-old mice 
were exposed to 6 Gy at ZT10 and were observed for 20 weeks (males) or 12 weeks 
(females).  (A) Male wild-type and Cry1-/-Cry2-/- mice; photographs were taken 20 weeks 
post-treatment.  (B) Female wild-type and Cry1-/-Cry2-/- mice; photographs were taken 12 
weeks post-treatment. 
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A 
WT ♂ Cry1-/-Cry2-/- ♂ 
B 
Cry1-/-Cry2-/- ♀ WT ♀ 
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Table 2.1. G2-M checkpoint in wild-type and Cry mutant fibroblasts after ionizing 
radiation treatments.  Exponentially growing cells were irradiated and at the indicated 
times were fixed, stained with propidium iodide, and analyzed by flow cytometry for DNA 
content.  The percentage of cells in G2 and M at 0, 8, and 24 h are shown in bold to highlight 
the G2-M arrest and subsequent recovery.  Percentages are average values from 3 individual 
experiments. 
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CHAPTER 3 
 
NEGATIVE REGULATION OF CLOCK-BMAL1 BY 
CRYPTOCHROME 
 
Summary 
 Although it is known that mammalian CRYPTOCHROME represses transcription by 
CLOCK-BMAL1, the biochemical mechanism by which this occurs is unknown.  In vitro 
experiments were performed to determine the direct effect of CRY1 on DNA binding of the 
CLOCK-BMAL1 heterodimer.  Assays were performed with purified mammalian BMAL1, 
CRY1, CLOCK, and CLOCK342 (a 342-aa truncation of CLOCK).  I find that, although 
experiments with full-length CLOCK are inconclusive, CRY1 has no observable effect on 
the binding of CLOCK342-BMAL1 to an E-box DNA substrate.  Additionally, I investigated 
the induction of CLOCK342-BMAL1 DNA binding by two agents, NADH and DTT in 
response to conflicting reports that NADH or DTT can increase the DNA binding of the 
heterodimer complex.  I find that under one set of reaction conditions, NADH can increase 
the DNA binding of the CLOCK342-BMAL1 heterodimer while DTT cannot, and under a 
slightly different set of conditions DTT can increase heterodimer DNA binding while NADH 
cannot.  The physiological relevance of these findings is in question, as the NADH 
concentrations used are likely out of the range of physiological levels and DTT is not a 
physiologically relevant agent.   
 
Introduction 
The current model of the mammalian molecular clock depicts a network of positive 
and negative transcriptional feedback loops (Figure 1.1).  In this model, the CLOCK-
BMAL1 heterodimer drives the positive arm of the feedback loop, activating transcription of 
the clock genes Period and Cryptochrome (along with other CCGs).  In the negative arm of 
the feedback loop, PER and CRY proteins negatively regulate their own expression by 
inhibiting CLOCK-BMAL1.  There is much genetic evidence and molecular evidence to this 
model:  Cry1-/-Cry2-/- knockout mice show elevated levels of Per1 transcript, while Per 
mutant animals show elevated levels of Cry transcript (Sancar, 2000; Fu et al., 2002);  
numerous reports have shown that CRY can inhibit activity of CLOCK-BMAL1 in luciferase 
reporter gene assays (Sato et al., 2006).  While both CRY and PER proteins repress CLOCK-
BMAL1, CRY1 and CRY2 have been shown to inhibit the complex more strongly than PER 
proteins (Maemura et al., 2000; Shearman et al., 2000; Gotter et al., 2000).  
Although it is known that CRY functions in the mammalian circadian clock as a 
repressor of CLOCK-BMAL1, the molecular mechanism by which this occurs is unknown.  
Recent studies in the mammalian system along with Drosophila and zebrafish have 
postulated numerous possible mechanisms.  The mammalian CRY proteins have been found 
to interact with CLOCK and BMAL1, by both yeast two-hybrid (Griffin et al., 1999) and 
immunoprecipitation assays (Lee et al., 2001). It is likely that this interaction is important for 
CRY’s negative regulation of CLOCK-BMAL1, either through direct or indirect effects on 
the complex, since it correlates with the time of highest CRY repression (Lee et al., 2001).   
One possible mechanism by which CRY represses CLOCK-BMAL1 is through 
modulation of post-translational modifications.  In Drosophila, phosphorylation of dCLOCK 
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has been shown to be dependent on PER, perhaps through PER-dependent entry of 
DOUBLE-TIME kinase into the CLOCK-CYCLE complex (Yu et al., 2006).  In the 
Neurospora circadian clock, posttranslational modification of not the White-Collar Complex 
(analogous to mammalian CLOCK-BMAL1, the transcriptional activator) but its regulator 
FRQ changes FRQ from a repressor to an activator. In the mammalian system, transcriptional 
activation of CLOCK-BMAL1 correlates with phosphorylation of both proteins, nuclear 
translocation, and subsequent degradation (Kondratov et al., 2003).  CRY may be involved in 
one or more of these posttranslational modifications, possibly through recruitment of a kinase 
or other protein-modifying enzyme.  It is important to note that phosphorylation of CLOCK 
and/or BMAL1 is not necessary for their heterodimerization; however, phosphorylation may 
be important for interaction with the negative regulators CRY and PER, as it is mainly 
hyperphosphorylated CLOCK that immunoprecipitates with these proteins (Lee et al., 2001). 
Chromatin modification is involved in the regulation of expression of many 
mammalian genes, and has been proposed as a key regulator of CLOCK-BMAL1-activated 
transcription.  Histone modification through both aceytlation and methylation has been linked 
to circadian clock gene expression.  Rhythms in histone H3 aceytlation and trimethylation 
have been correlated with circadian gene expression (Etchegaray et al., 2003; Ripperger and 
Schibler, 2006; Naruse et al., 2004).  In addition to CLOCK’s recently-identified histone 
acetyltransferase (HAT) activity (Doi et al., 2006), the HAT p300 has been shown to 
immoprecipitate with CLOCK in a time-dependent fashion; additionally, CRY inhibits a 
p300-induced increase in CLOCK-BMAL1-activated transcription (Etchegaray et al., 2003; 
Ripperger and Schibler, 2006).  Overexpression of p300 can overcome CRY2-mediated 
repression of NPAS2-BMAL1 (Curtis et al., 2004).  The PCAF and ACTR HAT proteins 
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also associate with CLOCK and its ortholog NPAS2 (Curtis et al., 2004).  WDR5, a 
component of a histone methyltransferase complex, has been found to associate with PER1 
(Brown et al., 2005).  Finally, the polycomb group enzyme EZH2, which catalyzes 
methylation of histone H3, associates with both CLOCK and BMAL1 (Etchegaray et al., 
2006).  Taken together, it is likely that histone and chromatin modification plays at least 
some part in regulation of clock gene expression. 
Due to the physical interaction of CRY with CLOCK and BMAL1, it is possible that 
CRY directly affects the CLOCK-BMAL1 complex’s DNA binding properties.  This could 
occur in a number of ways (Figure 3.1).  CRY could prevent CLOCK-BMAL1 from binding 
to E-box DNA, perhaps through formation of a trimeric complex or causing conformational 
change in the CLOCK-BMAL1 heterodimer (Figure 3.1, #1).  Such a mechanism has been 
proposed in the Drosophila circadian clock, where the negative regulators PER and TIM 
inhibit the DNA binding of CLOCK-CYC without appearing to disrupt the heterodimer itself 
(Lee et al., 1999).  Alternatively, CRY could form a trimeric complex with CLOCK-BMAL1 
that, while still binding to E-box DNA, is no longer transcriptionally active (Figure 3.1, #2).  
This has been implicated in the zebrafish circadian system, in which zCRY1a forms a large 
complex on DNA with zBMAL and zCLOCK (Ishikawa et al., 2002). A third possibility is 
that CRY disrupts the CLOCK-BMAL1 heterodimer by replacing one of the components 
(Figure 3.1, #3).  Although the aforementioned studies suggest mechanisms in the 
Drosophila and zebrafish clock systems, both studies are missing important experimental 
controls which are necessary for conclusions to be drawn.  The DNA-binding status of 
CLOCK-BMAL1 throughout the circadian cycle is somewhat controversial.  It has been 
reported that the CLOCK-BMAl1 heterodimer is constitutively bound to DNA throughout 
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the circadian cycle (Lee et al., 2001).  However, a recent report by Ripperger and Schibler 
contradicts this somewhat, showing that CLOCK-BMAL1 is rhythmically bound to E-box 
DNA and this binding is correlated with changes in chromatin modification and expression 
of the mouse clock-controlled gene Dbp (Ripperger and Schibler, 2006).   
In light of the conflicting evidence concerning the mechanism of CRY’s negative 
regulation of CLOCK-BMAL1, we examined the effect of CRY on direct DNA-binding of 
CLOCK-BMAL1 in in vitro DNA-binding assays.  We find that CRY has no effect on the 
DNA-binding of a heterodimer consisting of BMAL1 and CLOCK342, a 342-amino acid 
fragment of CLOCK.  Future studies must be done with purified full-length CLOCK to 
determine what the effect of CRY is on what is thought to be a more physiologically relevant 
protein. 
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Experimental Procedures 
 
Expression and Purification of Recombinant mBMAL1 and hCLOCK from SF-21 cells 
 
 mBMAL1 and hCLOCK proteins were expressed and purified from SF-21 cells as 
described in the Bac-to-Bac Baculovirus standard protocol (Invitrogen).  Baculovirus for 
expression of Flag-His-mBMAL1 was created by cloning into the pFastBac expression 
vector by Dr. Laura Lindsey-Boltz.  Flag-His-mBMAL1 has a single Flag and a single 6xHis 
tag N-terminal to mBMAL1.  Baculovirus for expression of Flag-hCLOCK was created by 
cloning into the pFastBac expression vector (by Dr. Christopher Selby) and the virus was 
prepared by Dr. Sezgin Ozgur.  Flag-hCLOCK has a single Flag tag N-terminal to hCLOCK.   
 For expression and purification of Flag-His-mBMAL1 and Flag-hCLOCK, 300 ml of 
SF-21 cells at a density of 1 x 106 cells/ml were inoculated with the appropriate virus (MOI = 
30-100).  Cells were incubated at 27° C for 48 hours after virus inoculation.  The cells were 
then harvested by centrifugation at 3000 rpm for 10 minutes and washed once with 1X 
phosphate-buffered saline (PBS).  The cell pellets were frozen and kept at -80° C until 
purification.  The cell pellets were subjected to three freeze-thaw cycles before lysis.  Cells 
were lysed in NP-40 lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 10% glycerol (v/v), 1% 
Tween-20 (v/v), 0.1% NP-40 (v/v)) by sonication (8 cycles of 30 seconds), Dounce 
homogenization (10 rounds), and, in the case of Flag-hCLOCK, shearing through a 22g 
needle; this led to 50-80% protein solubility in both cases.  Soluble cell lysate was prepared 
by centrifuging the cell lysis mixtures at 15000 rpm for 45 minutes at 4°C.  The supernatant 
was incubated overnight with Flag-agarose (Sigma; 150-300 μl packed resin) at 4°C.  The 
resin was then centrifuged at 4000 rpm for 5 minutes and flow-through removed and 
discarded.  The resin was washed with lysis buffer, tris-buffered saline (TBS) with 1M NaCl, 
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TBS, and TBS with 10% glycerol (15 ml each wash).  Bound protein was eluted in 200-400 
μl of elution buffer (TBS with 10% glycerol and 0.1 mg/ml Flag-peptide) and purification 
products were visualized using silver staining.  Protein concentration was determined using 
the Bio-Rad protein assay and absorbance at 595 nm. 
Expression and purification of His-mCLOCK342 in E. coli 
His-mClock342 had been previously cloned into the pet15b bacterial expression 
vector (Novagen) by Dr. Christopher Selby.  The expression construct was transformed into 
and expressed in BL-21 Gold (Invitrogen) bacterial cells.  His-mCLOCK342 expression was 
induced in 1 L of cells at an O.D. of 0.45 using 0.2 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) and shaking at room temperature for 8 hours.  Bacteria were 
harvested by centrifugation at 4000 rpm for 10 minutes and washed once with 1X PBS.  
Expression using this system resulted in nearly 100% insoluble His-CLOCK342 which was 
subsequently purified by extraction and salvation from inclusion bodies.  After washing with 
PBS, the cell pellet was resuspended in 20 ml of resuspension buffer (10 mM Tris pH 8.0, 
100 mM NaCl, 1 mM EDTA) and sonicated (5 cycles of 30 seconds).  The mixture was 
centrifuged for 10 minutes at 10000 rpm and the supernatant discarded.  The pellet was then 
resuspended in 20 ml of homogenizing buffer (50 mM Hepes pH 7.9, 2 mM EDTA, 0.1 mM 
DTT, 0.05% deoxycholate, 1% Triton X-100, 5% glycerol) and subjected to 10 cycles of 
Dounce homogenization.  Inclusion bodies were collected by centrifugation for 10 minutes at 
10000 rpm.  Inclusion bodies were then stirred overnight at 4°C in 40 ml of denaturing buffer 
(20 mM Hepes pH 7.9, 500 mM KCl, 0.2 mM EDTA, 2 mM DTT, 8M urea).  The 
resolubilized mixture was centrifuged to remove precipitate and the supernatant containing 
the solubilized His-CLOCK342 was dialyzed against storage buffer (20 mM Hepes pH 7.9, 
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100 mM KCl, 0.2 mM EDTA, 2 mM DTT).  Dialyzed protein was centrifuged to remove 
precipitate and soluble His-CLOCK342 was visualized using Coomassie staining.  Protein 
concentration was determined using the Bio-Rad protein assay and absorbance at 595 nm. 
Expression and purification of Flag-Myc-His-hCRY1 in HEK293T cells 
Flag-Myc-His-hCry1 had been previously cloned into the pcDNA4 mammalian 
expression vector (Invitrogen) by Dr. Carrie Partch.  The construct included a single Flag, a 
single Myc, and a single 6xHis tag at the N-terminus of hCry1.  This construct was 
transfected into HEK293T cells (20 150-cm plates; approximately 70% confluence) using 
standard calcium chloride transfection protocol.  After 48 hours, cells were harvested and 
washed once with 1X PBS.  Cells were lysed in NP-40 lysis buffer on ice for 20 minutes and 
then sonicated (5 cycles of 10 seconds); soluble cell lysate was prepared by centrifugation of 
the lysed cells at 15000 rpm for 45 minutes at 4°C.  The supernatant was incubated overnight 
with Flag-agarose (Sigma; 200 μl packed resin) at 4°C.  The resin was then centrifuged at 
4000 rpm for 5 minutes and flow-through removed and discarded.  The resin was washed 
with lysis buffer, tris-buffered saline (TBS) with 1M NaCl, TBS, and TBS with 10% glycerol 
(15 ml each wash).  Bound protein was eluted in 300 μl of elution buffer (TBS with 10% 
glycerol and 0.1 mg/ml Flag-peptide) and purification products were visualized using silver 
staining.  Protein concentration was determined using the Bio-Rad protein assay and 
absorbance at 595 nm. 
Electrophoretic Mobility Shift Assays (EMSAs) 
 EMSA was used to investigate the effect of hCRY1 on the DNA binding properties of 
the CLOCK-BMAl1 heterodimer.  Either a double-stranded 14mer containing a single E-box 
element (M34) or a double-stranded 58mer containing a single E-box element (E58), as 
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indicated in the figure legends, was used as the DNA probe in reactions at a concentration of 
approximately 1 nM.  Figure 3.3, panel A shows the sequences of the M34 and E58 
substrates.  The DNA probes were 5’-radiolabeled with 32P using a standard radiolabeling 
protocol.  Flag-His-mBMAL1, His-mCLOCK342, Flag-hCLOCK, and/or Flag-Myc-His-
hCRY1 were incubated at the indicated concentrations with 1 nM DNA probe in 25 μl 
reactions containing (unless otherwise indicated) 50 mM Tris pH 8.0, 100 mM KCl, 100 
μg/ml BSA, 1 mM EDTA, 8 mM DTT, 1 μg poly dI/dC, and 10% (v/v) glycerol for 20 
minutes at room temperature and 10 minutes at 4° C.  Reactions were loaded onto a pre-run 
4% nondenaturing polyacrylamide gel in 0.5X TBE (25 mM Tris-borate, pH 7.9, 0.6 mM 
EDTA) and electrophoresis was carried out at 4° C for approximately 3 hours.  After 
electrophoresis, the gel was dried and exposed to a PhosphorImager screen and analyzed by 
autoradiography using ImageQuant software.   
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Results 
Expression and Purification of Mammalian Circadian Clock Proteins 
Although genetic evidence shows that CRY inhibits transcriptional activation by 
CLOCK-BMAL1, there is little biochemical data indicating the mechanism by which this 
occurs.  For this reason, I decided to use a biochemical approach to answer this question, 
using electrophoretic mobility shift assays (EMSA) to directly assess the effect of CRY on 
CLOCK-BMAL1 DNA binding in an in vitro system.  Bacterial, baculovirus, and 
mammalian cell expression systems were used to purify CLOCK342, BMAL1, CLOCK, and 
CRY1 proteins (Figure 3.2).  The proteins were fused to small peptide tags to enable 
purification and to minimize any interference of the tags with protein folding or DNA 
binding.  Full-length hCRY1 (with N-terminal Flag, Myc, and 6xHis tags; Lane 2) was 
affinity-purified after transient transfection in HEK293T cells.  Flag-Myc-His-CRY1, of a 
molecular weight of ~65 kDa, was obtained in high purity using this system.  Full-length 
mBMAL1 (with N-terminal Flag and 6xHis tags; Lane 3) and hCLOCK (with a N-terminal 
Flag tag; Lane 5) were affinity-purified from SF-21 insect cells using the baculovirus 
expression system.  Flag-His-BMAL1, of a molecular weight of ~85 kDa, was obtained in 
high purity using this system.  Flag-CLOCK, of a molecular weight of ~105 kDa, 
consistently co-purified with a ~70 kDa contaminant protein.  This is likely Hsp70, perhaps 
associating with CLOCK due to its C-terminal poly-Q region.    
 Previously, a truncated from of mCLOCK containing the N-terminal 342 amino acids 
of the protein, which includes the bHLH and PAS domains, has been used successfully in 
EMSAs (Rutter et al., 2001).  A construct for bacterial expression of this protein (referred to 
here as CLOCK342) was obtained from Dr. Christopher Selby (UNC Chapel Hill).  
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CLOCK342 (with a N-terminal 6xHis tag; Lane 4) was expressed in and purified from E. 
coli; expression using this system generated exclusively insoluble protein that was 
subsequently purified from inclusion bodies.   
Effect of CRY on DNA-Binding of CLOCK-BMAL1 Heterodimers 
 Once the clock proteins were purified, their DNA-binding activity had to be 
determined.  This was done using electrophoretic mobility shift assays (EMSAs).  CLOCK-
BMAL1 activates transcription off of E-box DNA promoter elements (Gekakis et al., 1998) 
and has been shown to bind to E-box DNA elements specifically; therefore, as DNA 
substrates I used either a ds 14mer containing a single E-box (referred to as M34; Figure 3.3 
A) or a ds 58mer containing a single E-box (referred to as E58; Figure 3.3 B).  Under 
standard conditions, reactions containing full-length CLOCK alone result in a smear pattern, 
while CLOCK342 alone binds to DNA with extremely low affinity and again results in a 
slight smearing of the DNA (Figure 3.3 C, lanes 2 and 3).  BMAL1 has been shown to bind 
to DNA in the absence of CLOCK, presumably as a homodimer (Rutter, Reick, McKnight, 
Science 2001); I was able to reproduce this under standard conditions (Figure 3.3 C, lane 4).  
Formation of the CLOCK342-BMAL1 heterodimer was readily observable (Figure 3.3 C, 
lane 6), and was heavily favored over formation of the BMAL1 homodimer (compare lane 4 
to lane 6).  In comparison, when full-length CLOCK and BMAL1 were incubated together, 
although formation of the BMAL1 homodimer on DNA was inhibited, I was unable to 
observe discrete formation of CLOCK-BMAL1 heterodimer (Figure 3.3 C, lane 5).   For this 
reason, further experiments to determine the effect of CRY1 on heterodimer DNA-binding 
were performed using both the CLOCK-BMAL1 heterodimer and the CLOCK342-BMAL1 
heterodimer.   
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 Although CRY proteins share high homology with DNA photolyases, they lack any 
DNA repair activity (Sancar, 2000).  However, the similarity between the proteins suggests 
that CRY, like DNA photolyase, may also bind DNA in vivo.  Human CRY2 has been shown 
to bind to DNA, with a much higher affinity to single-stranded DNA than to double-stranded 
DNA; this binding was indifferent to DNA sequence but displayed a preference for DNA 
containing a (6-4) UV photoproduct (Ozgur and Sancar, 2003).  Human CRY1 also displayed 
DNA-binding activity on a double-stranded substrate with moderate-to-high affinity, 
qualitatively (Figure 3.4).  The previous work with hCRY2 suggests that hCRY1’s DNA-
binding activity is likely to be nonspecific, though this has yet to be conclusively determined.   
 I performed titration experiments with hCRY1 to determine the effect of increasing 
concentrations of the protein on the DNA-binding activity of the CLOCK-BMAL1 and 
CLOCK342-BMAL1 heterodimers.  Although I was unable to detect discrete formation of 
the CLOCK-BMAL1 heterodimer on DNA, I did observe a slow-migrating smear pattern 
which was unaffected by the addition of increasing concentrations of CRY1 (Figure 3.4).  I 
performed similar experiments using the CLOCK342-BMAL1 heterodimer, which formed a 
discrete species on DNA and led to more conclusive results.  These experiments were 
performed under conditions where CRY1 bound to DNA with both high affinity (Figure 3.5, 
left) and low affinity (Figure 3.4, right) to lessen the possibility that any inhibitory effect 
seen of CRY1 would be due to nonspecific competition.  In both cases, increasing 
concentrations of CRY1 had no observable effect on the DNA-binding intensity of 
CLOCK342-BMAL1.  These data would indicate that CRY1 does not affect the heterodimer 
by inhibiting its DNA-binding activity.  However, there are a number of caveats to this set of 
experiments.  First, it is possible that the type of assay used, EMSA, cannot observably 
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capture any inhibitory effect of CRY1 on the heterodimer.  Second, the truncated 
CLOCK342 protein may not be a physiologically relevant protein to use in this experiment.  
It may display an increased ability, relative to full-length CLOCK, to bind to DNA in the 
CLOCK342-BMAL1 heterodimer form, which could abrogate CRY1’s inhibitory effect.  
Also, as CLOCK342 is not full-length it may be missing a residue/motif necessary for 
repression and/or interaction with CRY1; this will be discussed further in the Discussion 
section.   
 It was also of interest to determine whether CRY1 can affect the binding of the 
individual clock proteins to DNA.  This is a relevant question due to the recent finding that 
CRY’s interaction with CLOCK and BMAL1 is increased when both CLOCK and BMAL1 
proteins are overexpressed, relative to interaction levels when only one of the proteins is 
overexpressed (Kiyohara et al., 2006).  Although a discrete DNA-binding species can only be 
seen in the case of BMAL1, it appears that CRY1 does not affect either discrete binding of 
BMAL1 homodimer to DNA or the lower-affinity binding of either CLOCK342 or CLOCK 
to DNA (Figure 3.6).   
Effect of NADH and DTT on CLOCK342-BMAL1 DNA-Binding Activity 
 It has been suggested that modulation of cellular redox state is the mechanism by 
which feeding entrains the circadian clock (Rutter et al., 2001).  Rutter and colleagues 
showed that addition of reduced NAD intermediates (NADH, NADPH), which change as a 
function of expression of lactate dehydrogenase (LDHA) during cellular respiration, increase 
DNA-binding activity of both NPAS2-BMAL1 and CLOCK-BMAL1 on a ds E-box DNA 
substrate.  However, experiments using homologous zebrafish clock proteins zfCLOCK2 and 
zfBMAL3 showed no NAD/NADH dependence, although increased concentration of DTT 
 70
resulted in increased DNA-binding activity of the heterodimer (Ishikawa et al., 2002).  
Additionally, previous experiments in our laboratory showed DTT-dependent enhanced 
DNA-binding of CLOCK-BMAL1 but no NAD/NADH dependence (data not shown).  It was 
therefore of interest to resolve this discrepancy.  Using standard conditions, identical to those 
used in previous experiments in our laboratory, addition of 10 mM NADH did not induce 
CLOCK342-BMAL1 DNA-binding; however, addition of 10 mM DTT resulted in a marked 
increase in heterodimer DNA-binding (Figure 3.7).  However, different results were obtained 
when conditions were adjusted to reflect those used by Rutter and colleagues (Rutter et al., 
2001).  These conditions, though still within physiological range, are slightly less stringent 
than the standard conditions used in my other experiments.  Using these reaction conditions, 
addition of NADH up to 10 mM dramatically increased the DNA-binding of CLOCK342-
BMAL1, while addition of DTT to 10 mM had no effect (Figure 3.8).  Because both the 
NAD/NADH effect and the DTT effect on heterodimer binding is very sensitive to slight 
changes in reaction conditions, it is difficult to assess the physiological relevance of either 
effect.  This will be discussed in more detail in the Discussion section.   
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Discussion 
Repression of CLOCK-BMAL1 by CRY1 
Despite much genetic evidence which led to proposal of the current mammalian clock 
model, biochemical evidence indicating the molecular mechanisms underlying the clock is 
generally lacking.  This is especially true in the case of mammalian CRYPTOCHROME, a 
protein whose in vivo biochemical function is still unclear.   
Determining the mechanism by which CRY inhibits transcriptional activation by 
CLOCK-BMAL1 will fill in a long-standing gap in the current clock model.  Data from 
previously published reports has shed some light on how the negative circadian feedback 
loop works in other model systems.  In zebrafish, zCRY1a forms a large complex with 
zfCLOCK2 and zfBMAL3 on DNA which is presumably transcriptionally inactive (Ishikawa 
et al., 2002).  A different mechanism is indicated in Drosophila, where negative regulators 
dPER and dTIM eliminate the binding of dCLOCK-CYC to DNA (Lee et al., 1999).  While 
distinct mechanisms are indicated in both zebrafish and Drosophila, in both systems negative 
regulation occurs through direct modulation of CLOCK-BMAL1 (or CLOCK-CYC) DNA-
binding.    Therefore, in the present study I investigated the possibility of direct modulation 
of CLOCK-BMAL1 DNA binding by CRY in the mammalian system.  Here I present 
evidence that, under the conditions of the experimental system used, mammalian CRY1 does 
not inhibit or otherwise affect the DNA-binding of the CLOCK-BMAL1 heterodimer.   
Although the data presented here indicates no effect of CRY1 on CLOCK-BMAL1, 
there is an important caveat to consider.  The experiments described used a truncated form of 
CLOCK containing only the first 342 N-terminal amino acids of the protein (CLOCK342).  
This protein has been shown to efficiently form a heterodimer with BMAL1 on E-box DNA 
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(Rutter et al., 2001; unpublished results from our laboratory).  However, the DNA-binding 
activity of this protein may not be identical to that of full-length CLOCK.  If CLOCK342 
binds to DNA in the heterodimer form with a much higher affinity compared to that of 
CLOCK, it is possible that the concentrations of CRY1 used are insufficient to affect 
CLOCK342-BMAL1 DNA binding.  An additional consideration to these experiments was 
brought to light in a recent report which identified CLOCK and BMAL1 mutations that 
eliminate repression by CRY.   A single mutation in residue 360 of CLOCK resulted in 
abrogation of repression of CLOCK-BMAL1 by CRY1 (Sato et al., 2006); this residue is 
notable because it is outside of the 342-aa fragment of CLOCK342.  This would again 
indicate that CLOCK342 may not be a physiologically relevant, as it lacks a residue that is 
necessary for CRY’s repression function.  There exists the possibility that the reason I saw no 
effect of CRY on CLOCK342-BMAL1’s DNA binding in my EMSA experiments is the 
absence of this key residue.  Taken together, these considerations illustrate the need to do 
these experiments with full-length mammalian CLOCK protein in order to ensure relevant 
activity levels and that all necessary residues are present in the proteins being used.  If the 
results of those experiments mirror those described here and again show no effect of CRY1 
on CLOCK-BMAL1 DNA-binding, it would suggest that repression by CRY1 is not 
achieved through modulation of DNA binding state, and would support the proposals that 
modification of chromatin and/or CLOCK-BMAL1 post-translational changes are more 
likely candidates for the pathway involved. 
Effect of NADH and DTT on CLOCK-BMAL1 DNA Binding 
Identification of the physiological factors that, in addition to light, can entrain the 
circadian cycle is crucial to fully understand the mechanisms underlying the clock.  It is 
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known that feeding cycles can entrain the mammalian clock, and one proposal for how this 
occurs is through inducing rhythmic changes in the redox state of nicotinamide adenine 
dinucleotide cofactors.  Rutter and colleagues demonstrated by EMSA that increasing 
concentrations of NADPH and NADH induce DNA binding of NPAS2-BMAL1 and 
CLOCK342-BMAL1 (Rutter et al., 2001); they surmised from these data that changes in 
cellular NAD redox state, which would give rise to NADPH and NADH, could be the 
mechanism by which feeding entrains the clock.   
However, there are questions as to the physiological relevance of the aforementioned 
data.  This effect was not seen with homologous zebrafish clock proteins (Ishikawa et al., 
2002), although an increase in CLOCK-BMAL1 heterodimer DNA binding was seen upon 
addition of increasing concentrations of dithiothreitol.  In my experiments, I was able to 
reproduce induction of CLOCK342-BMAL1 DNA binding by DTT; after slight changes in 
reaction conditions, I was also able to replicate induction by NADH.  Because both sets of 
reaction conditions were within physiological ranges (with the exception of NADH and/or 
DTT concentration), the relevance of either effect is suspect.  Additionally, the 
concentrations of NAD cofactors used by Rutter and colleagues are likely much higher than 
mammalian cellular concentrations reach, by at least a factor of ten, perhaps much more 
(Bergmeyer, 1974; Tischler et al., 1977; O’Donnell and Kuhn, 1997).   
 
In conclusion, there is a clear need for further experiments both to determine the 
relevance of induction of CLOCK-BMAL1 DNA binding by NADH and/or DTT and to fully 
elucidate the mechanism by which CRY represses clock-activated gene transcription.  
Biochemical experiments similar to those described here will be crucial to understand the 
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molecular mechanisms underlying the mammalian clock.  This will be especially useful in 
the current re-evaluation of the TTFL mammalian circadian clock model.   
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Figure 3.1. Possible Mechanisms for CRY’s Negative Regulation of CLOCK-BMAL1 
by Directly Affecting DNA Binding.  CRY may directly affect CLOCK-BMAL1 by (1) 
changing the conformation of CLOCK-BMAL1, possibly by forming a trimeric complex, 
such that the complex no longer binds to DNA; (2) forming a trimeric complex on DNA 
which no longer is transcriptionally active; or (3) replacing one of the components of the 
CLOCK-BMAL1 heterodimer to form a transcriptionally inactive complex on DNA. 
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Figure 3.2. Purified hCRY1, mBMAL1, mCLOCK342, and hCLOCK proteins.  
(Lane 1) Molecular weight marker.  (Lane 2) Flag-Myc-His-hCRY1, purified from transient 
transfection of 293T cells.  Protein was purified to a concentration of approximately 314 nM.  
(Lane 3) Flag-His-mBMAL1, purified from baculovirus infection of SF-21 insect cells.  
Protein was purified to a concentration of approximately 312 nM.  (Lane 4) His-CLOCK342, 
purified from inclusion bodies in E. coli.  Protein was purified to a concentration of 
approximately 2 μM.  (Lane 5) Flag-hCLOCK, purified from baculovirus infection of SF-21 
insect cells.  Protein was purified to a concentration of approximately 115 nM.  * denotes a 
contaminant, likely heat-shock protein.  Proteins were visualized by silver-staining. 
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Figure 3.3. Formation of CLOCK342-BMAL1 and (possible) CLOCK-BMAL1 
Heterodimer on E-box DNA.  (A) M34 DNA substrate sequence.  (B) E58 DNA substrate 
sequence.  (C) EMSAs were carried out as described using E58 ds radiolabeled DNA.  (Lane 
1) DNA alone.  (Lane 2) DNA + CLOCK.  (Lane 3) DNA + CLOCK342.  (Lane 4)  DNA + 
BMAL1.  (Lane 5) DNA + CLOCK + BMAL1.  (Lane 6) DNA + CLOCK342 + BMAL1.  
Arrows denote DNA-protein complexes.  Protein concentrations used:  CLOCK (20 nm), 
BMAL1 (50 nm), CLOCK342 (80 nm).    
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A   
 
5’ GGGACACGTGACCC  3’ 
3’ CCCTGTGCACTGGG  5’    
 
 
B 
 
5’ CATCACCCACTCACCCCTTACTACACGTGGGCCCTCAATTGCCCTTCTCCAGGATCTG     3’ 
3’ GTCGTGGGTGAGTGGGGAATGATGTGCACCCGGGAGTTAACGGGAAGAGGTCCTAGAC     5’ 
 
 
 
C 
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Figure 3.4. Effect of CRY1 on Binding of CLOCK-BMAL1 to E-box DNA.  EMSAs 
were carried out as described using E58 ds radiolabeled DNA.  Arrows indicate the binding 
of BMAL1-BMAL1 homodimer, CLOCK-BMAL1 heterodimer, or CRY1 to DNA.  Protein 
concentrations used:  BMAL1 (50 nm), CLOCK (20 nm), CRY1 (14-100 nm).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 82
  
 
 
 
 
 
 
 
 
 
 
 83
Figure 3.5. Effect of CRY1 on Binding of CLOCK342-BMAL1 to E-box DNA.  
EMSAs were carried out as described using E58 ds radiolabeled DNA under conditions of 
either high CRY1 DBA-binding affinity (left panel) or low CRY1 DNA-binding affinity 
(right panel).  Arrows indicate the binding of BMAL1-BMAL1 homodimer, CLOCK342-
BMAL1 heterodimer, or CRY1 to DNA.  Protein concentrations used:  BMAL1 (50 nm), 
CLOCK342 (80 nm), CRY1 (14-100 nm).    
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Figure 3.6. Effect of CRY on DNA-Binding of BMAL1, CLOCK342, and CLOCK 
Individual Proteins.  EMSAs were carried out as described using E58 ds radiolabeled DNA 
under standard conditions. Arrows indicate the binding of BMAL1-BMAL1 homodimer, 
CLOCK342-BMAL1 heterodimer, CLOCK342, CLOCK, or CRY1 to DNA.  Protein 
concentrations used:  CLOCK (20 nm), BMAL1 (50 nm), CLOCK342 (80 nm), CRY1 (10-
40 nm).    
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Figure 3.7. Effect of NADH and DTT on DNA-Binding of CLOCK342-BMAL1 
heterodimer under standard conditions.  EMSAs were carried out using the M34 DNA 
probe under standard conditions without DTT:  50 mM Tris pH 8.0, 100 mM KCl, 100 μg/ml 
BSA, 1 mM EDTA, 0.5 μg poly dI/dC, and 10% (v/v) glycerol for 20 minutes at room 
temperature and 10 minutes at 4° C.  10 mM DTT or 10 mM NADH was included in the 
reaction as indicated.  Protein concentrations used:  BMAL1 (20 nm), CLOCK342 (50 nm).    
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Figure 3.8.  Effect of NADH and DTT on DNA-Binding of CLOCK342-BMAL1 
heterodimer under low-stringency conditions.  EMSAs were carried out using the M34 
DNA probe under low-stringency conditions:  10 mM Tris pH 7.5, 50 mM KCl, 1 mg/ml 
BSA, 1 ug poly dI/dC, and 10% glycerol for 30 minutes at room temperature.  DTT or 
NADH was included in the reaction as indicated; concentrations ranged from 1.25 mM 
(lowest concentration) to 10 mM (highest concentration).  Protein concentrations used:  
BMAL1 (50 nm), CLOCK342 (50 nm).    
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CHAPTER 4 
FINAL DISCUSSION AND FUTURE DIRECTIONS 
 
 The development of life on Earth would not have been possible without the sun’s 
energy.  Although this is a well-known concept, the extent to which the sun has shaped 
evolution of Earth organisms is even more remarkable.  The first advent of adaptation to the 
daily solar cycle is thought to have been necessary to protect replicating genetic material 
from damage by ultraviolet light during Precambrian times before the protective ozone layer 
developed.  The absence of the ozone layer resulted in heavy daily exposure to ultraviolet 
radiation for Earth organisms, forcing them to adapt in order to survive.  To avoid UV, which 
can penetrate 25 meters of clear water, metazoans descended deep into the oceans during the 
daytime and migrated closer to the surface at night.  Blue light is the only wavelength in the 
visual spectrum that can penetrate deep ocean water.  Consequently, blue light became the 
cue for the organisms’ internal timekeeping mechanism (Gehring and Rosbash, 2003).  
The evolutionary adaptation demonstrated by the metazoans has extended into an 
extremely complex set of pathways in organisms ranging from cyanobacteria to humans.  
These pathways, called circadian clocks, synchronize behavioral processes, metabolism, 
hormone production, cell division, and a host of other important cellular processes to the 
daily solar cycle.  Although organisms possess endogenous ~24 hour rhythms, entrainment 
by light-time signals synchronizes endogenous clocks to the precise 24 hour cycle of the 
Earth’s rotation.  Again, blue light is likely the most important wavelength of light in this 
process, evidenced by the fact that the human eye is most sensitive to blue light.   
Clearly, the effect of light on Earth organisms is extensive, and expanding our 
understanding of how we adapt to light-time signals will be a great scientific step.  Perhaps 
the newly-discovered model system of Danaus plexippus, the monarch butterfly, will be 
especially helpful in achieving greater understanding of circadian clock mechanisms in 
animals.  A sophisticated clock exists in the monarch butterfly, indicated by their complex 
yearly migration pattern which uses light to signal the fall and early spring journeys, for 
long-range navigation, and to cause seasonal variations in reproduction.  While the more 
characterized Drosophila system has only one CRY (insect-like) and the mammalian system 
has two similar CRYs which are somewhat divergent from Drosophila, Danaus possesses 
both an insect-like CRY and a mammalian-like CRY (Reppert, 2006).  This discovery has led 
to Danaus’s emergence as a new model system for the animal circadian clock and study of 
this system will greatly increase our understanding of how CRY functions and, more 
generally, of the mechanisms underlying the clock.   
 Here I describe experiments to further characterize the role of CRY in cancer 
predisposition and as a negative regulator of CLOCK-BMAL1.  Various reports link 
circadian clock disruption to increased risk of breast cancer in humans (Hansen, 2000; 
Stevens, 2005), and mice with SCN ablation exhibit a faster rate of growth of transplanted 
tumors (Filipski et al., 2002).  Furthermore, mice with a mutant form of Per2 are 
hypersensitive to IR-induced mortality and have an abrogated DNA damage checkpoint (Fu 
et al., 2002).  Although circadian disruption is indicated as a possible cancer risk factor, the 
mechanism through which this occurs is unknown.  My experiments with Cry1-/-Cry2-/- mice 
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show no predisposition to cancer or abrogation of DNA damage checkpoints relative to wild-
type, indicating that circadian disruption per se does not increase cancer risk.  This does not 
rule out involvement of circadian proteins with cell cycle; indeed, reports suggest that a 
function of the PER family of proteins, possibly outside of their clock role, is the connection 
between circadian rhythms and cancer (Fu et al., 2002; Gery et al., 2006; Hua et al., 2006).  
Further characterization of circadian control of the cell cycle will be key to both the possible 
establishment of clock disruption as a cancer risk factor and the use of chronotherapy, which 
seeks to maximize efficacy of chemotherapy while minimizing side effects through 
modulation of time of treatment (Hrushesky, 1995).   
 The mechanism by which CRY represses CLOCK-BMAL1 activity has been as 
“cryptic” as the protein’s name suggests.  Work with Drosophila and zebrafish proteins has 
indicated that in both organisms, negative regulation of CLOCK-BMAL1 by its repressors is 
achieved through effects on the DNA binding of the complex (Lee et al., 1999; Ishikawa et 
al., 2002).  If one of these mechanisms was preserved in mammals, it would logically follow 
that CLOCK-BMAL1’s binding to DNA would be rhythmic.  However, reports on this are 
conflicting:  there is evidence that the complex is constitutively bound to DNA (Lee et al., 
2001), and a recent report claims rhythmic binding (Ripperger and Schibler, 2006).  In order 
to clarify these conflicting reports, I used purified proteins to examine the effect of CRY1 on 
CLOCK-BMAL1 (using a 342-aa fragment of CLOCK, CLOCK342) in in vitro DNA 
binding assays.  I show here that CRY1 does not change the DNA binding of CLOCK342-
BMAL1.  This is a notable finding as it would indicate that mammalian CRY represses 
CLOCK-BMAL1 by a mechanism distinct from that in other animal systems.  However, it is 
possible that CLOCK342 is not a physiologically relevant protein for use in these assays as it 
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is missing a residue recently discovered to be crucial to repression of the heterodimer by 
CRY (Sato et al., 2006).  Therefore, to conclusively determine if CRY directly affects the 
DNA binding of CLOCK-BMAL1, these experiments must be repeated with full-length 
CLOCK.  Additionally, I investigated the effect of both NADH and DTT on induction of 
CLOCK-BMAL1 DNA binding in response to previous reports (Rutter et al., 2001; Ishikawa 
et al., 2002).  This phenomenon is of interest because modulation of cellular redox state has 
been proposed as the pathway by which feeding entrains the circadian clock (Rutter et al., 
2001).  I find that in conditions where NADH induces heterodimer DNA binding, DTT does 
not; and in conditions where DTT induces heterodimer DNA binding, NADH does not.  
Based on these data, the physiological relevance of the effect of either NADH or DTT is in 
doubt.   
 Overall, these experiments contribute to our overall understanding of the mammalian 
circadian clock.  However, ever more biochemical evidence is needed in order for us to fully 
comprehend this complex mechanism.   
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